Serenity Aleabitoreddit

Serenity Supply-Chain Lens (@aleabitoreddit)

⚠️ STEP 0 — ALWAYS REFRESH BEFORE USE. This skill goes stale within ~30 minutes.

Its theses, track record, and analysis are regenerated from @aleabitoreddit's

live feed roughly every half hour, so the copy on disk is very likely out of

date by the time you read it. Before reading any references/*.md /

analysis/*.md file or giving any view, pull the latest version first:

>

```bash

skills update serenity-aleabitoreddit -y # auto-detects project vs global scope

```

>

Then read the refreshed reference files and proceed. Only if the update

genuinely fails (offline / network error / command missing) should you fall

back to the cached copy — and if you do, say explicitly that the data may be

stale.

A reusable analytical lens distilled from 5,857 tweets (2025-07 to 2026-06) plus 4 long-form X Articles (2026-01 to 2026-05) by Serenity / [@aleabitoreddit](https://x.com/aleabitoreddit) — an AI-and-semiconductor supply-chain analyst and trader (~500k followers, ~40k subscribers, ex-Reddit/WSB). Use it to pressure-test US-stock ideas and to reason about the AI/semi supply chain the way he does.

Decision-support lens, NOT financial advice and NOT an auto-trader. See

"Risk & disclaimer framing" below. Always confirm current prices and

fundamentals yourself — theses decay, and his returns are self-reported and

unverified.

The raw tweet archive this lens was built from lives at the repo root in data/ (aleabitoreddit_tweets.json / .csv); the period-by-period distillation is in analysis/.

---

Who Serenity is and what his edge is

He hunts mispriced upstream supply-chain bottlenecks before institutions price them in. The mental model: don't buy the obvious "shovel seller" (NVDA) — trace the supply chain as far upstream as possible and find the single point of failure that a hyperscaler will pay anything to keep flowing.

His representative chain:

hyperscaler capex (GOOGL/MSFT/META/AMZN) → ASICs/TPUs → optical transceivers

(LITE/AAOI/COHR) → InP epiwafer (IQE) → InP substrate (AXTI/Sumitomo) → InP

feedstock (indium, Vital Materials).

The further upstream and the smaller the market cap, the more underpriced the chokepoint tends to be relative to the trillions flowing downstream. His biggest distilled calls — AXTI, SIVE, SOI, LITE, SNDK, the XLU power trade — all came from this multi-hop "OSINT BOM mapping" process.

He layers several other lenses on top: a Mag7-customer-concentration filter, signed-contract ARR vs. market-cap mismatch, a GAAP-margin war (real margins vs. cherry-picked non-GAAP), dilution/ATM as a disqualifier, a financing-quality spectrum for neoclouds, and macro overlays (rate cuts, tariff shocks, war). Full detail in references/methodology.md.

Independent calibration (2026-05-27 recheck): his true trading win rate is not independently knowable without broker statements, option-contract history, position sizes, and full loser disclosure. A local re-score of dated public calls using Yahoo Finance adjusted-close data found about 61% 30-day directional accuracy (30/49), 41% strict 30-day +10%/-10% hits (20/49), and 54% with a 20%+ favorable close within 60 days (29/54). Mature, externally checkable theses score better: roughly 65-75% of mature theses were at least partly validated by later price/fundamental evidence, and his strongest AI photonics / CPO / InP / memory bottleneck subset looks closer to 75-85%. Treat those as rough calibration bands, not a replicable trading return.

Signal timing calibration (2026-06-11 recheck): his best supply-chain posts are usually not reliable 1-day copy-trade signals. The repeatable pattern is often 5-60 trading days from public thesis to market validation, as company orders, media coverage, institutional ownership, or local-market attention catch up. Same-day or same-week reactions are more likely only when the post combines (1) a fresh, underpriced bottleneck, (2) a concrete external catalyst such as an order, filing, policy item, or named customer path, and (3) a small/illiquid equity where local media or retail attention can move the float. Treat late mainstream validation, victory laps, and broad supplier lists as research inputs, not fresh entry signals.

Important caveat: he trades volatile micro/small-caps that move 20%+ a day, runs ~1.25–1.5x margin, and self-reports very high YTD returns (237% in Feb 2026, later 4502.45% YTD on May 26). Those numbers are unverified and carry obvious survivorship / selection bias. Treat his lens as a source of questions to ask, not signals to copy.

---

How the reference files are organized

Read progressively — pull in only what the task needs.

---

Workflows

(a) Evaluate one ticker through his lens

1. Look the ticker up in references/theses.md. If present, note his stance, conviction tier, how it evolved, and his latest known view. Flag if his view reversed (e.g. IREN, CRWV, POET). 2. If the ticker or theme appears in references/articles.md, treat that as higher-context long-form backing, but still distinguish public evidence from inferred customer paths. 3. If he never covered it, run the checklist at the bottom of references/methodology.md — apply his principles to a fresh name. 4. Sanity-check timeliness: his theses are dated. Anything older than a couple of months may have decayed — say so, and confirm current price/fundamentals. 5. Weight his opinion using references/track-record.md and the calibration bands above: his bottleneck theses deserve more weight than event trades, old flipped stances, or self-reported options screenshots. 6. Present: his view, the supply-chain read, the bull/bear case, and the risks — framed as analysis, never as an order to place.

(b) Review a portfolio or watchlist against his views

1. Take the list of tickers the reader provides (their holdings, a watchlist, a sector basket). 2. For each name, pull his view from references/theses.md and bucket into:

• Agreements — he is bullish on it.
• Conflicts — he is bearish/cautious on it (surface his dated reasoning).
• Gaps — his high-conviction names absent from the list (e.g. the

photonics/CPO chain: SIVE/LITE/COHR/AAOI/SOI/AXTI/TSEM/IQE; NBIS among neoclouds; SNDK for memory). 3. Check references/articles.md for long-form article support. Article-backed signals should raise discussion priority only when they also fit the user's risk budget, liquidity, and execution constraints. 4. Produce a prioritized discussion list. Keep it advisory; never generate, place, or cancel a trade order.

(c) Form a forward sector view

1. Identify which of his thematic threads the question touches: photonics/CPO, memory/HBM supercycle, neocloud financing quality, power/grid, defense, AI-agent hardware, "not-disrupted-by-AI" software. 2. Pull the relevant theses and thread summaries from references/theses.md. 3. Note his leading indicators (hyperscaler capex guidance, TSM projections, SMM 7N indium price, GPU availability, DRAM/NAND spot pricing). 4. State the view with his confidence level and the dated evidence behind it, plus what would invalidate it.

(d) Decide whether fresh posts imply an investment window

Use this when the user asks whether his recent posts, a cluster of X threads, or a market pullback create a current buying window.

1. Pull the latest skill data first, then inspect the fresh post text, replies, quotes/search echoes, and the matching entries in references/theses.md and references/track-record.md. 2. Classify the post type before talking about execution:

• New bottleneck thesis: a fresh, underpriced supply-chain dependency with

named customers, capacity constraints, or policy/filing evidence. Highest weight, but still requires price and risk checks.

• Reaffirmation / buy-the-dip: he already owns or has high conviction,

and the pullback appears tied to a false report, mechanical selloff, ATM overhang, or misunderstood earnings. Medium-high weight if external checks support his mechanism.

• Supplier map / watchlist / no-position idea: useful for research and

future watchlists, but not a standalone buy signal.

• Victory lap / mainstream validation: confirms an old thesis worked; it

often means the easy mispricing has already compressed. Do not treat it as a new entry unless valuation and positioning reset. 3. Compare the fresh signal against historical analogs from track-record.md. Focus on whether the setup matches the mechanism of prior winners, not just whether the ticker/theme is adjacent. Many past winners initially chopped or fell before 20-60 day validation. 4. Check the market window separately from the stock thesis: broad breadth, sector uptrend participation, theme crowding, macro/event risk, and whether leadership is broadening or narrowing. A strong Serenity thesis inside a weak or narrow market is a selective/left-side window, not a green light. 5. Convert the result into an action discipline, not an order: maintain existing high-priority limit ladders, lower trigger prices, or add a watch rule when the setup is early; avoid near-price chasing when the post is only a supplier list, late validation, or social-media heat.

---

Risk & disclaimer framing (state this when giving any view)

• Self-reported, unverified returns. His YTD figures, from 237% in Feb 2026

to 4502.45% on May 26, are his own screenshots. No independent verification exists.

• Estimated public-call calibration, not trading proof. A 2026-05-27

recheck found ~61% 30-day directional accuracy on dated public calls, but only ~41% strict 30-day +10%/-10% hits. Mature supply-chain theses validated better than mechanical copying.

• Survivorship / selection bias. A public feed highlights winners. Reversed

or wrong calls exist (see references/track-record.md) and get less airtime.

• High-volatility micro/small-caps. Many of his names (AXTI, SIVE, IQE, AAOI)

move 20%+ in a day, have thin floats, dilution risk, and binary outcomes. His position sizing and margin use are not appropriate to copy blindly — he says so himself ("build conviction yourself before entering").

• Theses decay. Calls are dated. A bottleneck can resolve, a contract can be

lost, an ATM can be filed. Always re-confirm current price and fundamentals.

• This is a lens, not a signal feed. Use it to ask better questions about

your own ideas. It is explicitly NOT auto-trading, NOT a recommendation to buy/sell, and NOT financial advice. Every order is the reader's own manual, confirmed decision.

• No-position idea posts carry lower weight. If he frames a stock comment as

exploratory, for fun, or explicitly says he has no position, treat it as a process example rather than a high-conviction call.

Analysis: 2025-07 to 2025-09

Corpus window: 2025-07-02 to 2025-09-30. Total tweets in slice: ~394 (40 in July, 10 in August, 344 in September). This is Serenity's earliest period on X — account appears to have launched mid-2025, building from a Reddit/WSB base.

---

A. Methodology signals

How he hunts supply-chain / market signals

• Customer concentration as the primary moat signal. He repeatedly asks "who are the customers?" before sizing a position. The ALAB thesis launched with: "the only small cap company in existence with systemic exposure to 5 of the Mag7" (2025-07-28). For NBIS: "MSFT, GOOGL, and Mag7 are your customers... a company's forward growth would likely explode in the 100%'s of percent" (2025-09-19). Mag7 customer presence is his highest-conviction filter.
• Forward revenue vs. market cap mismatch. He prices stocks on forward ARR implied by signed contracts rather than trailing multiples. On NBIS: "MC: 24.78B... By 2026, with Microsoft deal accounted for, NBIS could be doing $5-6B total revenue... This is insane" (2025-09-19). Same framing on UPWK at 7.5x trailing P/E vs. cash-rich balance sheet (2025-07-21).
• Signed contract size as the de-risking event. Before NBIS's $17B MSFT contract he considered the stock speculative; after: "before $50 NBIS was speculation... Now it's pure scaling from here" (2025-09-21). Contract signing is his threshold for switching from "watch" to "high conviction."
• Capex funnel logic / "who is the real bottleneck." His NeoCloud thesis (2025-09-27): "Trillions of capex that normally flowed through AWS, MSFT Azure... will now funnel into NeoClouds when they can't handle new AI loads." He traces hyperscaler compute strain downstream to small GPU-as-a-service companies, identifies them as the real bottleneck in AI infra.
• NVDA moat-preservation logic. He argues NVDA has an active incentive to prop NeoCloud GPU lenders (CRWV, NBIS) to prevent compute consolidation at Azure/AWS, which would compress NVDA margins. "NVIDIA has every reason to inflate GPU lenders like CoreWeave and NBIS to hedge against hyperscaler custom chips." (2025-09-19). This is his structural reason the trade is durable.
• Sector spread / "things rise together." He buys CRDO when ALAB runs because "usually things rise together (eg. $CRWV + $NBIS)" (2025-07-21). He buys TSSI when SMCI/TSM rally because "Semi rally extended back to server racks" (2025-09-09). Sector contagion drives entry.
• Short interest as a squeeze timer, not a directional signal alone. He tracks float-adjusted short interest closely: HIMS 42% SI with 34-36% borrow utilization (2025-09-10), noting shorts are "trapped if buying pressure continued." He maps against profitable/growing fundamentals to argue the squeeze is inevitable. "42% short interest on a 11B, profitable, and fast growing company... has the potential to make history on a short squeeze like OPEN or GME" (2025-09-12, 195 likes).
• Dilution analysis / lockup calendars. He reads SEC EDGAR filings for dilution terms. On CRCL: "TA doesn't mean anything with upcoming share lockups... The full 180 day lock up is December 2nd and you have another $10B+ USD of potential selling pressure in two months" (2025-09-16). On CIFR: fundraising "38%+ above current market rate" is bullish; CRWV's 9% interest rate is a negative vs. NBIS's better terms. Dilution quality is part of his scorecard.
• IPO float arbitrage. Early July: "I was doing arbitrage earlier, it was clear BULL was going to crash from $70 once warrants could be redeemed" (2025-07-03). He read warrant-to-stock mispricing at IPO. He spots similar dynamics in CRCL.
• Catalyst identification and front-running. His explicit method: "Know what a real catalyst is and buy beforehand. Real = 2B+ from S&P flowing into HOOD MC on inclusion. Fake (for shorts) = CFO resigning." (2025-09-14). He uses Polymarket odds and Bloomberg ETF-approval probabilities to size catalyst plays (e.g., LTC ETF at 90-95% Polymarket odds). He explicitly ignores Reddit/X sentiment ("IGNORE the sentiment since it's usually wrong").
• Option flow and market-maker behavior. He reads open-interest imbalances as directional signals. On UPWK: "Market makers flushed Upwork call open interest for August 15th, and now it's rallying" (2025-08-23). On SG: "10k+ $8 puts 9/19 caused MM shorts, not fundamental changes" (2025-09-09). He uses weekly OI expiry as a timing device.
• Macro as a portfolio-tilt mechanism. The September fed triple-rate-cut projection triggers a systematic tilt to small-caps/growth: "Triple rate cut only happens once a decade (extremely positive for liquidity flowing into markets)" (2025-09-18). He adjusts allocations from defensive/value (UNH, NVO) to growth/small-cap on rate-cut signals.
• Photographic memory claim, cross-market synthesis. Self-described: "I have photographic memory where I can remember option flow/earnings report/market cap/macro event off the top of my head and piece things together on the fly" (2025-09-10). His process is explicitly multi-variable, synthesizing fundamentals + option flow + catalyst timing + macro simultaneously.

Risk management and position sizing

• Cost-averaging down in tranches: "buy say 30% of your position after today's 18.75% drop, then have cost averages down to the low" (2025-07-02 on OSCR).
• Position sizing by conviction tier: $175K initial in ALAB (Jul) scaled toward $500K; $500K in NBIS (Sep 19) scaled toward $1M+. He labels these explicitly: "highest conviction stock for a 1 year time period" with $225 PT.
• Anti-full-port discipline: "I never recommend full porting on dips" (2025-07-02). Exception only for NBIS given MSFT contract de-risking.
• Options only when IV <32-33% (rule of thumb): "I mainly recommend calls for super low IV stocks (10-35%) like GOOGL or UNH" (2025-09-05). He breaks this rule selectively for extreme dislocations (e.g., IREN -14% on JPM note = calls OK).
• Covered-call income as a core return layer: "Same rate would be ~157K+ over 2 years" on IBIT CCs (2025-07-28). He models CC income as a second return stream on all large holdings.
• Seasonality awareness: "Lower risk appetite around September" (2025-08-25). He reduces high-beta exposure in Sep and reloads Oct-Dec: "November-December is also one of the strongest periods for equities."

Recurring mental models / catchphrases

• "Follow the leader": when sector leader rallies, buy lagging peers in the same sector.
• "Dilution was already priced in": if a stock only rises 45% on a 300%+ revenue contract, the dilution was baked in, making the dip after dilution announcement a buy (NBIS, 2025-09-10).
• "Float and fundamentals > lines on a chart": contrasted against TA charting, which he dismisses systematically.
• "Mag7 as customers = highest conviction filter."
• NeoCloud stack analogy: "NVDA / TSM (2022->): GPU for hyperscalers. CRDO / ALAB (2024 ->): parabolic growth. NBIS/CIFR/IREN (2025-): AWS/Azure capex -> parabolic growth." (2025-09-27).

---

B. Per-ticker theses

$NBIS — NeoCloud / GPU-as-a-Service (Nebius)

• Stance: Ultra-high conviction bull. Largest position disclosed in the corpus. Conviction: maximum.
• Thesis: NBIS is the best-positioned NeoCloud because (a) $17B MSFT contract over 5 years provides the highest de-risked forward revenue ramp of any peer, (b) NVDA has strategic incentives to support GPU lenders to prevent Azure/AWS compute consolidation, (c) valuation at ~$24-26B MC is wildly mispriced relative to $5-6B projected 2026 revenue at ~70% gross margins, (d) macro tailwind from triple rate cut lowers debt cost and re-rates far-out earnings higher.
• Evidence/catalysts cited (dated):
• 2025-09-09: MSFT contract of $17B confirmed. "Just tripled their yearly revenue" (300%+ ARR impact).
• 2025-09-10: NBIS dilution of $3B capital raise; he argues dilution was "already priced in" since stock only rose 45% not 250%+ on the contract.
• 2025-09-19: "By 2026, with Microsoft deal accounted for, NBIS could be doing $5-6B total revenue with strong gross margins (~70%). In 2027-28, total revenue could reach $8-10B+."
• 2025-09-19: $4.1B+ raised at good terms (above current market price) for MSFT capex.
• 2025-09-27: META gives CRWV $14B contract — cited as bullish signal for all neoclouds including NBIS.
• 2025-09-29: CRWV up 12% on META contract news; NBIS held $111, described as a "dip during a rally."
• Calls/targets/entries-exits (dated):
• 2025-09-09: Bought $100K of NBIS after $17B MSFT contract announced.
• 2025-09-15: Strong buy at $90 on any dip.
• 2025-09-19: Bought $500K of NBIS. Price target $225. "My highest conviction stock out of anything for a 1 year time period."
• 2025-09-21: Disclosed $ALAB ran 154% since July call; drawing same thesis parallel for NBIS.
• 2025-09-22: Reiterated buy; "screaming buy under $130. $200 PT, 5 months" (762 likes post on Sep 23).
• 2025-09-23: $200 PT, 5-month horizon; also mentions $225 PT in other posts.
• 2025-09-24: Disclosed $750K+ position, ~$93K unrealized gain in 5 days.
• 2025-09-26: Added $100K of NBIS calls on 4.6% dip to $103.
• 2025-09-27: Total NeoCloud allocation described as "$1.5M+."
• 2025-09-29: "Extremely Strong Buy" at $111.91 in Monday Market Close post.
• Stance changes: None in this period. Position built from $0 to $750K+ between Sept 9–24 with stated intent to scale to $1M+.

---

$UPWK — Software / Freelance Platform

• Stance: Value bull (long), moderate-high conviction. Not a hypergrowth play; a valuation-normalization trade.
• Thesis: Severely mispriced at 7.5x trailing P/E with 78-80% gross margins, $622M+ cash, $770M annual revenue, and buybacks. Margin expansion from cost-cutting + AI automation could push operating margins from 20% to 40-60%, implying 3-4x upside on operating income re-rating.
• Evidence/catalysts cited (dated):
• 2025-07-02: Bought $150K+ shares. "9 tailed fox pattern" TA (meme framing, not serious signal); serious thesis = 7.5x P/E + 78% gross margins + $622M cash at $1.74B MC.
• 2025-07-21: Supplemented with serious fundamental case: "Who cares about revenue growth when they can just scale operating margins?"
• 2025-08-06: Earnings beat — operating margin expansion confirmed. "All they needed to do was expand operating margins on their 78% gross margins and they did."
• 2025-08-23: Post-earnings follow-up at $17.5+. "Market makers flushed Upwork call open interest for August 15th."
• 2025-09-03: $100M share buyback announced (~5% float). Reiterated as "most undervalued and immensely profitable stock."
• 2025-09-10: Trimmed around $16.5-$17. "At $11-14 it was completely undervalued. At $16 it's still undervalued." PT: $20-25.
• 2025-09-24: Acknowledged total position return ~50%+ from initial entry.
• Calls/targets/entries-exits (dated):
• 2025-07-02: Entry ~$13-14 range (implied by "bought $150K+"). PT $17+.
• 2025-08-06: Held through earnings.
• 2025-09-10: Trimmed $16.5-$17. PT $20 fair value; $25 if acquisitions deliver.
• 2025-09-29: Listed as "Hold" in Monday Market Close.
• Stance changes: Entered as high-conviction value long (Jul); trimmed on strength (Sep 10) but held residual position. No full exit.

---

$ALAB — Semiconductor / AI Interconnect (Astera Labs)

• Stance: Strong bull (Jul-Aug), transitioned to cautious/profit-take (Sep 8).
• Thesis: Only small-cap semi with systemic Mag7 customer exposure (GOOGL, MSFT, NVDA, META, AMZN). 144-150%+ YoY growth, 76% profit margins (higher than NVDA). "NVDA started at 150B market cap -> 4 Trillion+ because hyperscalers needed GPUs. We're the start of this effect with ALAB."
• Evidence/catalysts cited (dated):
• 2025-07-21: $16B MC, 144%+ Y/Y growth, 76% margins, Mag7 customers. Bought $175K+.
• 2025-07-21: Same day, ALAB up 16%; did not take profit ("another NVIDIA 500%+ type stock").
• 2025-07-28: Thesis reinforced after GOOGL earnings showed continued AI capex increase.
• 2025-09-21: ALAB had risen 154% since Jul entry ($96 -> $244). Used as precedent for NBIS thesis.
• Calls/targets/entries-exits (dated):
• 2025-07-21: Entry ~$96-100 area (implied). Target: "potential $50B+ moonshot" from $16B MC. Planned to scale to $500K.
• 2025-07-21: Added $100K CRDO same day as ALAB buy (sector companion trade).
• 2025-09-08: Took profit at $217 (~100%+ gain from ~$99 cost average). "ALAB feels a bit overbought after going up 14%... opened up short with CREDO as a hedge."
• 2025-09-29: Listed as "Hold" in Monday Market Close.
• Stance changes: Long -> profit-take + short hedge at $217 (2025-09-08). Described as "tad overvalued" at $244 by Sep 21.

---

$CRDO — Semiconductor / AI Interconnect (Credo Technology)

• Stance: High-conviction bull, positioned as ALAB peer-catchup trade.
• Thesis: Growing at 180% Y/Y (per Jul tweets, citing "180% y/y growth"), serving XAI/AWS/MSFT customers. Should "catch up to ALAB MC" — i.e., if ALAB is at $38B MC, CRDO deserves similar. Persistent as a "follow the leader" sector play.
• Evidence/catalysts cited (dated):
• 2025-07-21: Bought $100K after ALAB ran up. "Similar market segments and it dropped 8% last week. Usually things rise together."
• 2025-09-08: Used as an ALAB short hedge ("opened up short with CREDO as a hedge" — context suggests short-term technical hedge, not a fundamental short).
• 2025-09-11: Listed in top-5 picks: "$CRDO - Just to catchup ALAB MC." Entry <$125.
• 2025-09-26: Added CRDO DCA ~$142. "Just thought it might rebound in Oct."
• 2025-09-29: "Buy" at ~$142 in Monday Market Close.
• Calls/targets/entries-exits (dated):
• 2025-07-21: Entry at ~$100 area (implied, CRDO was near that level). PT: ALAB parity ($38B MC).
• 2025-09-16: Ideal entry <$125.
• 2025-09-26: DCA $142.21.

---

$HIMS — Healthcare / Telehealth (Hims & Hers)

• Stance: High-conviction bull, short-squeeze catalyst thesis layered on fundamental growth.
• Thesis: 42% short interest on a profitable ($2B+ annualized revenue, 69-88% YoY growth), growing company is an anomaly. EU acquisition of 1.2M+ customers (Zava deal) not priced into forward estimates. Shorts are paying borrow fees on ~$4.5B. Eventual short cover = squeeze. Rate cut is an additional catalyst for high-SI growth stocks.
• Evidence/catalysts cited (dated):
• 2025-08-25: "Short interest up to 34.59% of float and ~$3B+ USD / 9.7B market cap." Bought at $42.
• 2025-09-10: SI increased to 42%. "36%+ short interest means hedge funds are nearing limits of how much they can borrow."
• 2025-09-10: BTIG reiterates buy / $85 PT. Citi reiterates sell / $30 PT (dismisses Citi: "they pull numbers out of thin air").
• 2025-09-11: Testosterone product launch + PPI data cited as squeeze catalysts; shorts increased another 6% to 42%+ to suppress breakout at $50.
• 2025-09-12: 195-like tweet: "42% short interest on a 11B, profitable, and fast growing company… has the potential to make history."
• 2025-09-16: Entry ideal <$45.
• 2025-09-18: Dismissed Citi $30 PT; called out analyst conflict (shorts have $4.5B on the line).
• 2025-09-30: Dipped on Trump drug-price website announcement. Commented: "AMZN launching a competitor, HIMS crashed 20% then rose again, I'd expect the same... near term it's a headwind."
• Calls/targets/entries-exits (dated):
• 2025-07-07: Bought $45.26 on 5.6% drop. Early entry.
• 2025-08-25: Reiterated buy at $42. "Easy buy + hold until the shorts unwind."
• 2025-09-08: Listed in rising stocks on high-beta rally day.
• 2025-09-10/11: Held through testosterone launch; shorted added, stock moved to ~$57 from ~$48 entry.
• 2025-09-11: Top-5 picks: HIMS #1, entry <$45. PT: "up to $100 on surprise news."
• 2025-09-29: "Hold" in Monday Market Close at $56.4 after Trump drug news.

---

$TSM — Semiconductor / Foundry (TSMC)

• Stance: High-conviction bull on 1-2 year basis; described as "safest full port" for lower-risk investors.
• Thesis: Pure monopoly on advanced semiconductor manufacturing. Hyperscaler capex spending (NVDA, AVGO, ORCL, NBIS backlogs) flows to TSM. "Undervalued and a monopoly, will likely run from $1.3T -> $1.8T MC based on forward growth + capex from ERs." (2025-09-11). "If you're debating ORCL vs AMZN, AMD vs AVGO vs NVDA — just buy TSM, everything above is dependent on it."
• Evidence/catalysts cited (dated):
• 2025-09-10: Bought calls (~$253 entry) after sector rally extended. Said "rarely buy calls aside from GOOG back at $150 but IV is decent ~32 and it's such a great company."
• 2025-09-10: Calls up 68% by Sep 19.
• 2025-09-19: Sold all TSM calls at $175 for "100%+ profit." Rotated into NBIS.
• 2025-09-22: Sold TSM calls.
• 2025-09-24: Disclosed TSM calls profit ~"$100K+."
• Calls/targets/entries-exits (dated):
• 2025-09-10: Entry ~$253 on calls (scaled to ~$300K in leaps per thread).
• 2025-09-10: PT $1.8T MC (from ~$1.3T at entry).
• 2025-09-22: Exited calls at 100%+ profit, ~$175 stock price.
• 2025-09-29: "Buy" at $277 in Monday Market Close but "not a screaming buy like sub $250."

---

$HOOD — Fintech / Brokerage (Robinhood)

• Stance: Strong bull (early Sep), degraded to "sell/trim" at elevated levels.
• Thesis: S&P 500 inclusion drives passive flows into market-cap-weighted index; HOOD at $100B+ MC will receive "2B+ from S&P." New product lines (banking, etc.) add forward revenue not priced in. "Might be PLTR v2."
• Evidence/catalysts cited (dated):
• 2025-09-05: S&P 500 inclusion announced. Bought $325K on inclusion day. "Huge money flows coming into Robinhood given market cap soon."
• 2025-09-05: New product launch Tuesday + banking coming soon cited.
• 2025-09-14: Listed as a "real catalyst" example for his trading-style explainer thread.
• 2025-09-14: Cited as past successful trade (HOOD +22.21% after his entry).
• 2025-09-29: Listed as "Sell" at $130+ (up 12.27% that day). Day-traded.
• Calls/targets/entries-exits (dated):
• 2025-07-02: Early mentions alongside crypto-adjacent fintech.
• 2025-09-05: Bought $325K on S&P inclusion. Went up ~15% next day.
• 2025-09-29: Selling/trimming at $130+.

---

$RKLB — Aerospace / Small Launch (Rocket Lab)

• Stance: Highest-conviction 5-year hold. No active trading conviction in this period; used as swing-trade vehicle.
• Thesis: Only meaningful comparison is SpaceX ($350B). Full-stack capability (small-to-medium launch + Neutron medium-lift + Flateline satellite services). "Space is a national security issue" = durable demand regardless of private sector cycles. Neutron launch planned early 2026 is the next major catalyst.
• Evidence/catalysts cited (dated):
• 2025-09-09: Mentioned in bullish rate-cut stocks basket.
• 2025-09-11: Top-5 picks: RKLB #4, entry <$42.
• 2025-09-16: Ideal entry <$42. "For RKLB just hold it for 5-8 years, should be $350B market cap like SpaceX one day."
• 2025-09-29: "Hold" in Monday Market Close. Swing-traded between $43-$53 intraday (multiple occasions).
• Calls/targets/entries-exits (dated):
• 2025-09-16: Entry <$42. 5-year PT: $350B MC (vs. ~$10B at time).
• 2025-09-26: Swing-trade entry ~$46.29.
• 2025-09-29: "Fun swing trade between $43 -> $53." Not a near-term catalyst play.

---

$IREN — NeoCloud / BTC Mining + HPC pivot (Iris Energy)

• Stance: Speculative bull within NeoCloud basket. Lower conviction than NBIS; higher conviction than pure BTC miners.
• Thesis: Bitcoin mining company pivoting to HPC/GPU compute. "Reminds me of NBIS following CRWV's massive rise" (2025-09-03). Once it secures a Mag7 HPC contract (like NBIS/CIFR), upside materializes. Until then, more speculative.
• Evidence/catalysts cited (dated):
• 2025-09-03: First serious look after IREN rose past $30.
• 2025-09-08: Did not enter; passed in favor of NBIS.
• 2025-09-26: Bought IREN shares at $40.13 on 13% drop (JPM price target event). Added $15K short-term calls.
• 2025-09-28: Confirmed IREN in NeoCloud bucket but "more speculative atm + needs dilution."
• 2025-09-29: "Hold" in Monday Market Close.
• Calls/targets/entries-exits (dated):
• 2025-09-26: Shares at $40.13. Short-term calls $15K.
• 2025-09-28: Comment: "$IREN would likely hit $80 before end of year" if NBIS doubles to $225+.

---

$CIFR — NeoCloud / BTC Mining + HPC (Cipher Mining)

• Stance: Speculative bull. Lower conviction than NBIS; good dilution terms make it buyable.
• Thesis: $3B Google-backstopped deal over 10 years. At $4-5B MC vs. the deal size, asymmetric. "4B MC for a company powering GOOGL cloud is hilarious forward rev potential." (2025-09-27). Key differentiator from CRWV: zero interest on dilution vs. CRWV's 9%.
• Evidence/catalysts cited (dated):
• 2025-09-17: First mention in small-cap exploration post ($4.8B MC).
• 2025-09-25: GOOGL-backstopped deal confirmed. "Good buy on the 17.54% drop... 0% interest (unlike CRWV 9%) is really positive."
• 2025-09-26: Bought $30K Jan calls at $11 strike on 5% dip. Added $50K total.
• 2025-09-29: "Buy" in Monday Market Close at ~$11-12 area. PT: $16.
• Calls/targets/entries-exits (dated):
• 2025-09-25-26: $30K calls, then $50K total. Jan expiry, $11 strike.
• 2025-09-29: PT $16 near-term. "GOOGL backstopped now just execution."

---

$IBIT — Bitcoin ETF (BlackRock)

• Stance: Long-term bull. Used for covered-call income generation on top of BTC appreciation.
• Thesis: Pure BTC exposure via ETF; sell weekly covered calls against long position for ~1% weekly yield. 44-55% IV makes CC premium substantial. USD printing / macro tailwinds push BTC to $120-140K in 2025. Trump policy favorable (BTC acquisitions).
• Evidence/catalysts cited (dated):
• 2025-07-02: Bought IBIT 2026-2027 Leaps at 44-55% IV. CCs netting $6,557+ realized in 2 months.
• 2025-07-28: Unrealized $44K+ on IBIT position. "Low risk, asymmetric upside."
• 2025-08-26: Cited as contrarian buy at $110K BTC when Peter Schiff called for $75K.
• 2025-09-16: Listed in top-15 as entry <$112.5K (BTC price).
• 2025-09-26: Buying IBIT at $109.5K BTC.
• 2025-09-29: "Hold" in Monday Market Close.
• Calls/targets/entries-exits (dated):
• 2025-07-02: Leaps bought.
• 2025-07-28: $44K+ unrealized + $6.5K CC income.
• 2025-09-16: PT: BTC $120K+ in 2025.

---

$KSPI — Fintech / Kazakhstan (Kaspi.kz)

• Stance: Value bull. High-conviction buy on dip.
• Thesis: Rare combination of 47% Y/Y revenue growth + 31% profit margins + 7.9x P/E in fintech. Compared favorably to HOOD/SOFI/BULL. Geopolitically distant from conflict zones.
• Evidence/catalysts cited (dated):
• 2025-07-31: Bought $100K+ at $82 after 7.2% weekly drop. Planned to scale to $250K cost average.
• Calls/targets/entries-exits (dated):
• 2025-07-31: Entry $82. Scale plan to $250K.

---

$ETOR — Fintech / European Broker (eToro)

• Stance: Value bull, acknowledged as a timing miss.
• Thesis: ~$800M+ net cash on $3.3-3.6B MC, growing 22% Y/Y (comparable to IBKR), profitable. "Market is pricing this wrong" — compared to HOOD/BULL growing 40%+ but at much higher valuation. Main headwind: Cathie Wood buying (inverse signal), tax harvesting, sentiment.
• Evidence/catalysts cited (dated):
• 2025-07-02: First mention at $63.1.
• 2025-08-23: Listed as recovery/swing trade at $46.8.
• 2025-08-25: Noted "lower risk appetite around September" context.
• 2025-09-10: Held ETOR position; disclosed as "cost-avg loss so far this year."
• 2025-09-16: Entry ideal <$48. Listed #6 in top-15 (behind NBIS, HIMS, LTC, RKLB, TSM).
• 2025-09-29: "Extremely Strong Buy" at $39 in Monday Market Close.
• Calls/targets/entries-exits (dated):
• Various entries, cost-avg down; disclosed as only losing position in period.
• 2025-09-29: $39 = Extremely Strong Buy.

---

$GOOGL — Mega-cap / Cloud (Alphabet)

• Stance: Long (shares and calls). Reliable value + growth anchor.
• Thesis: AI capex cycle beneficiary. Strong buybacks. "They still have 70B+ in buybacks" (2025-07-28). Used as a recurring low-IV options example (28% IV).
• Evidence/catalysts cited (dated):
• 2025-07-03: Listed as long. Bought calls ~$150 for WSB post; sold $175; rebought $164.
• 2025-07-28: Earnings blowout. Realized $101,428+ profit on calls. "Expect GOOGL to hit $220+ EOY."
• 2025-09-10: APPL event listed as gamble; GOOGL not mentioned as a sell.
• Calls/targets/entries-exits (dated):
• 2025-07-03: Calls ~$150. Sold $175. Rebought $164.
• 2025-07-28: $101,428+ realized. EOY PT: $220+.
• 2025-09-23: Macro PT: $GOOGL -> staying with $META -> $2.3T, $AMZN -> $3T, $TSM -> $1.8T framework.

---

$CRCL — Crypto / Stablecoin (Circle)

• Stance: Fundamental bear at elevated prices. Not a short, but a structural "avoid."
• Thesis: Circle is a stablecoin interest-income business. At >$200, its market cap exceeds half of Coinbase, which is structurally wrong given COIN receives 50% of USDC interest income. Full lockup on Dec 2 adds $10B+ selling pressure.
• Evidence/catalysts cited (dated):
• 2025-07-03: IPO lockup awareness (180-day lockup = Dec 2 unlock).
• 2025-09-16: "If you ever see CRCL at $200, it's an easy short Circle long Coinbase play." Taught TA uselessness lesson using CRCL/BULL float dynamics.
• 2025-08-23: Listed as "stay away."
• 2025-09-29: Listed as "Sell."
• Calls/targets/entries-exits (dated):
• 2025-09-16: Structural short signal above $200 (vs. COIN parity math).
• Dec 2, 2025: $10B+ unlock event flagged as forward risk.

---

$PLTR — Software / Defense (Palantir)

• Stance: Bear/short. Cited as "cult stock detached from fundamentals."
• Thesis: Large part of profit is just interest income; core business growth not warranting valuation. "Large part of their profit is just interest income." (2025-09-29). Shorted at $150+ after Cramer pump.
• Evidence/catalysts cited (dated):
• 2025-07-28: "Shorting $PLTR, thanks Jim" — shorted after Cramer called it through $150.
• 2025-08-23: Listed as "stay away."
• 2025-09-29: "Sell" in Monday Market Close.

---

$LTC — Crypto (Litecoin)

• Stance: Tactical bull ahead of ETF launch catalyst.
• Thesis: Oct 2, 2025 ETF launch (Polymarket 90-95% approval odds). Small $8B MC means LTC reserves post-launch will eat majority of supply; 5-15% already permanently lost. "Frontrun institutions for the ETF launch Oct 2nd." PT: 300% potential; $200+.
• Evidence/catalysts cited (dated):
• 2025-09-12: Entered. LTC up 5.35% same day. ETF Oct 2, 2025.
• 2025-09-13: "Potential 300% in the next few months." 8B MC + institutional adoption.
• 2025-09-14: Framed ETF filing timing and Polymarket odds as key inputs.
• 2025-09-16: Listed as top-5 at <$120.
• 2025-09-29: "Buy" in Monday Market Close. Queried why still at $106 with 3-4 day ETF approval.
• Calls/targets/entries-exits (dated):
• 2025-09-12: Entered LTC. Price approx $100-106.
• 2025-09-16: Entry <$120.
• 2025-09-29: "Buy"; PT: $200+.

---

$SMCI — Semiconductor / Servers (Super Micro Computer)

• Stance: Tactical buy on oversold rebound, not a high-conviction hold.
• Thesis: "33B forward revenue 2026. 24B market cap lol. One good earnings and it pops off." (2025-09-16). Classic misvaluation: forward-rev based re-rating play.
• Evidence/catalysts cited (dated):
• 2025-09-09: Semi rally extended to server racks. TSSI context.
• 2025-09-16: Entry <$45. Listed in top-15.
• 2025-09-29: "Buy" at ~$45.
• Previously: admitted missing $500K+ gain on SMCI and not selling on time.

---

$TSSI — Server Racks / Data Center (TSS Inc.)

• Stance: Tactical bull on semi-sector spread.
• Thesis: Down from $30+ to $13-14 from dilution. SMCI/TSM semi rally should extend to server rack adjacent plays. "Semi rally extended back to server racks."
• Evidence/catalysts cited (dated):
• 2025-07-03: First mention at $8. "TSSI is quite amazing back when they were $200m or so."
• 2025-09-09: Bought $40K at $13.6. TSSI up 5.2% two hours later, then 9.44% by end of day.
• 2025-09-10: Held. PT: back to $30 range.
• 2025-09-16: Entry <$13.5. Listed in top-15.
• 2025-09-29: Small position ".2%" in recommended portfolio.

---

$MRVL — Semiconductor / Networking (Marvell)

• Stance: Buy on oversold dip.
• Thesis: 45-55% YoY growth, "unfairly punished after earnings" -18% drop.
• Evidence/catalysts cited (dated):
• 2025-09-02: "$MRVL 18% drop after earnings was a complete overreaction. Perfect time to DCA into Marvell positions over the next month."
• 2025-09-16: Ideal entry <$70. Listed in top-15.
• 2025-09-25: DCA mentioned.
• 2025-09-29: "Buy" in Monday Market Close.

---

$NVDA — Semiconductor (Nvidia)

• Stance: Hold. Too large/expensive to be a primary position; used as ecosystem anchor for thesis generation.
• Thesis: 4T company supported by hyperscaler GPU demand. NeoCloud thesis is predicated on NVDA's moat-preservation behavior. "Hold" — not a buy at current levels per Sep 29 post.
• Evidence/catalysts cited (dated):
• 2025-07-28: Used in ALAB thesis context ("same effect with ALAB for AI supply chain").
• 2025-09-10: Part of AI semi rally basket.
• 2025-09-29: "Hold" in Monday Market Close.

---

C. Thematic threads

• NeoCloud / Hyperscaler Capex Funnel (dominant theme from Sep 17 onward): NBIS, CIFR, CRWV, IREN, WULF, BITF, RIOT, MARA, CLSK, HUT, WYFI, GRRR, SLNH — all framed as recipients of Mag7 AI capex that can no longer be absorbed by AWS/Azure/GCP alone. NVDA enables and benefits from this. Bucket hierarchy: Mag7-contracted (NBIS, CIFR, WULF, CRWV) > with compute but no Mag7 deal yet (IREN, BITF) > speculative (WYFI, GRRR, SLNH) > BTC miners pivoting (RIOT, MARA, CLSK, HUT). The key bottleneck: AI compute for frontier model training/inference.

• Semi sector spread / "follow the leader": NVDA run -> AVGO run -> TSM run -> ALAB/CRDO run -> TSSI/SMCI catch-up. Each step is a lagging-sector trade. TSM is the foundational "everything above is dependent on it" anchor.

• Short squeeze on profitable growth companies: HIMS (42% SI), GME (cult + CEO cash pile), RKT (60%+ SI). He distinguishes between "profitable + growing company with high SI" (HIMS = inevitable squeeze) vs. "zombie company with high SI" (OPEN = dangerous, people didn't sell on spike).

• Crypto / macro inflation hedge: IBIT (BTC), LTC (ETF catalyst), MSTR (BTC treasury). USD debasement from "Big Beautiful Bill" + 10-11% M2 expansion = inflation hedge rationale. BTC $120-140K target for 2025. Sell ETH at $4K+ (L2 value leakage thesis, hinted but not fully written in this period).

• Value investing basket (anti-thesis to NeoCloud for stable capital): UPWK, KSPI, ETOR, UNH, NVO, GOOGL, TGT — characterized by P/E <15, large cash positions, profitable with margins. Described as "tax loss averaging" opportunities going into year-end. Defensive tilt for risk-off macro scenarios.

• IPO / dilution arbitrage: BULL, CRCL — limited float dynamics at IPO create disconnected price from intrinsic; lockup expiry is the catalyst for mean reversion. He explicitly positions against or avoids these once lockups approach.

• Rate-cut macro tilt (Sep 18 onward): Triple rate cut projection from Fed = once-in-a-decade liquidity event. Specifically bullish for: small caps (debt cost), growth/NeoCloud (far-out earnings re-rated up), Russell 2000 ETF flows. Changes portfolio tilt from defensive to aggressive.

---

D. Dated calls (track-record timeline)

• 2025-07-02 — $UPWK — Bought $150K+ shares ~$13-14. Value thesis: 7.5x P/E, 78% gross margins, $622M cash.
• 2025-07-02 — $IBIT/$BTC — Bought 2026-2027 LEAPS at 44-55% IV. BTC $120-140K target for 2025.
• 2025-07-02 — $ETORO — Flagged as "great add at $63.1" (crypto broker lagging $HOOD/$BULL).
• 2025-07-03 — $GOOGL — Held calls from ~$150; sold $175; rebought $164. EOY PT: $220+.
• 2025-07-07 — $HIMS — Bought $45.26 on 5.6% drop.
• 2025-07-07 — $BULL — Bought on 15% drop at $12.28.
• 2025-07-07 — $SG — Bought $13.80 on 6% drop.
• 2025-07-21 — $ALAB — Bought $175K+ ~$96-100. PT: $50B+ MC ("NVIDIA of AI interconnect"). Planned scale to $500K.
• 2025-07-21 — $CRDO — Bought $100K. Companion to ALAB on same-day sector trade.
• 2025-07-28 — $GOOGL — Realized $101,428+ profit on earnings blowout. EOY PT: $220+.
• 2025-07-28 — $IBIT — Disclosed $44K+ unrealized + $6,557 in realized CC income after 2 months.
• 2025-07-28 — $PLTR — Shorted after Cramer $150+ call ("Shorting PLTR, thanks Jim").
• 2025-07-31 — $KSPI — Bought $100K at $82. Plan to scale to $250K.
• 2025-08-06 — $UPWK — Earnings beat confirmed margin expansion; reiterated as hold to $17-23.
• 2025-08-23 — $UPWK — Reiterated post MM flush as value play; rallying to $17.5+.
• 2025-08-25 — $HIMS — Reiterated buy at $42. SI up to 34.59%.
• 2025-08-31 — Moonshot basket — $RKLB ($220B PT), $CRWV ($470B), $CREDO ($200B), $TSSI ($3.8B), $BKKT ($1.8B), $BMBL ($6.2B), $HIMS ($95B), $UPWK ($19B) — published 5-year 1000% basket.
• 2025-09-02 — $MRVL — "18% drop after earnings was complete overreaction. Perfect time to DCA."
• 2025-09-03 — $UPWK — $100M buyback announced. Reiterated as "most undervalued profitable stock."
• 2025-09-05 — $HOOD — Guessed S&P 500 inclusion pre-announcement ("saw my deleted post guessing inclusion"). Bought $325K on inclusion day; up 15%+ next day.
• 2025-09-05 — $BULL — Bought $100K following HOOD S&P inclusion. "Follow the lead."
• 2025-09-08 — $SG — Bought $100K at $8.22 on 8.2% drop with no news.
• 2025-09-08 — $ALAB — Took profit at $217 (~100%+ gain from ~$99 cost). Opened CRDO short as hedge. ("Feels overbought.")
• 2025-09-09 — $NBIS — Bought $100K after $17B MSFT contract. Called "huge buying opportunity."
• 2025-09-09 — $TSSI — Bought $40K at $13.6. Up 9.44% same day.
• 2025-09-09 — NBIS — Dilution dip "bought out" — free 6% same day. Prediction confirmed within hours.
• 2025-09-10 — Day-trade report: TSSI +9.44%, HIMS +6.94%, NBIS +5.71%, TSM (leverage) +3.23%, ETOR -3.33%.
• 2025-09-10 — $TSM — Bought calls ~$253. "Rarely buy calls aside from GOOG."
• 2025-09-10 — $UPWK — Trimmed at $16.5-17. PT $20-25. Position ~50%+ profit.
• 2025-09-11 — Top-5 picks for next month: (1) HIMS, (2) LTC, (3) NBIS $100+, (4) RKLB <$42, (5) HOOD.
• 2025-09-12 — $HIMS — "42% short interest on 11B profitable growing company... potential to make history." (195 likes, 34K views)
• 2025-09-12 — $LTC — Entered position. Up 5.35% same day. ETF Oct 2, 2025.
• 2025-09-13 — $LTC — "300% potential in next few months." PT: $200+.
• 2025-09-14 — Disclosed 630%+ 1-year portfolio return (screenshot, 575K views).
• 2025-09-16 — Top-15 catalyst stocks list published (28K views). Full ranked list with entry levels.
• 2025-09-16 — $CRCL — "TA doesn't mean anything with upcoming share lockups." Dec 2 unlock = $10B+ selling pressure. Structural short >$200.
• 2025-09-17 — Small-cap exploration post: APLD, CIFR, ONDS, NVTS, MVST — hunting 10x+ names.
• 2025-09-18 — $TGT — Bought calls ~$100K (November 12 dividend catalyst; admitted Oct timing error).
• 2025-09-18 — $ABAT — Blindly followed follower tip; worked out ("returned quite a bit").
• 2025-09-18 — Triple rate cut thesis published. "Once-in-a-decade opportunity."
• 2025-09-19 — $NBIS — Bought $500K. PT $225. "Highest conviction stock for 1-year timeframe." (439 likes, 79K views)
• 2025-09-19 — $NBIS full thesis published — Macro + fundamentals + moat + NVDA incentive alignment. (209 likes, 58K views)
• 2025-09-19 — $TSM calls — Up 68% since Sep 10 entry. Sold all for 100%+ profit.
• 2025-09-21 — $ALAB — Confirmed 154% return since July call ($96 -> $244). Used as NBIS precedent.
• 2025-09-22 — $NBIS — "Screaming buy under $130. $200 PT, 5 months." (185 likes, 28K views).
• 2025-09-23 — $NBIS — "Once-a-decade stock. Screaming buy under $130. $200 PT, 5 months." (340 likes, 40K views).
• 2025-09-23 — $AMZN — "Great buy at $220." PT: $3T MC.
• 2025-09-23 — Recommended portfolio weighting published: 30% NBIS, 6% AMZN, 5.5% TSM, 5% BTC, etc. (257 likes, 95K views — highest-engagement post in period).
• 2025-09-24 — $NBIS — Disclosed $750K+ position, ~$93K unrealized in 5 days.
• 2025-09-24 — $BKKT — Called out as serial diluter; dismissed as "terrible shill."
• 2025-09-25 — $CIFR — Researched after follower request; good dilution terms (0% interest, 38%+ above market). "Good buy on 17.54% drop."
• 2025-09-26 — $CIFR — Bought $30K Jan calls at $11 on 5% dip.
• 2025-09-26 — $NBIS — Added $100K calls on 4.6% dip to $103.
• 2025-09-26 — $IREN — Bought shares at $40.13 on 13% dip.
• 2025-09-26 — $ORCL — DCA calls at $284 on 2.4% dip. "Too much forward rev potential with OpenAI, TikTok."
• 2025-09-27 — NeoCloud mega-thesis published: "$1.5M+ into Neoclouds, 200-300%+ return potential." (880 likes, 1.2M views — highest-reach post in period).
• 2025-09-29 — Monday Market Close: Full rated portfolio published. Extremely Strong Buy: NBIS, ETOR, LTC, VIRT. Strong Sell: OKLO, QBTS, IONQ. (762 likes, 335K views).
• 2025-09-30 — $NBIS — Daily market thoughts: CRWV +12% on META contract = bullish signal for all neoclouds. NBIS "dip during rally" at $111.
• 2025-09-30 — $HIMS — Trump direct-consumer drug website announced. "Near-term headwind. Prefer to wait for $50 entry."

---

Note on methodology maturity: This is Serenity's earliest X period (~2-3 months on the platform). His framework is already fully formed — the NeoCloud capex funnel thesis, short-interest squeeze methodology, dilution calendars, and macro tilt logic are all present from the first weeks. The account appears to have transferred a well-developed Reddit DD approach directly to X. The Sep 27 NeoCloud thesis post (1.2M views) represents his first viral breakout moment and the consolidation of his framework into a single shareable thesis.

Analysis: 2025-10 to 2025-11

Source: @aleabitoreddit (Serenity) tweets, Oct 1 – Nov 30 2025 Corpus slice: ~829 tweets (490 Oct + 339 Nov)

---

A. Methodology signals

1. GAAP-normalized margin comparison as first filter Serenity insists on comparing Neocloud companies on GAAP gross margin, not non-GAAP or segment-specific metrics. When IREN reported "92% gross margins" Serenity immediately flagged it as hardware-specific non-GAAP, not comparable to NBIS's 71.2% GAAP gross margin (reported Nov 11). The working rule: if a company's margin disclosure strips out stock-based comp, depreciation, or restricts to one revenue line, treat it as uninformative for cross-company comparison.

2. Software-ownership as the margin wedge The core analytical lens: full-stack Neocloud providers that own their GPU orchestration software achieve 50–75% GAAP gross margins; bare-metal/colo operators (CIFR, WULF, IREN) achieve high topline but structurally lower margins because they rely on third-party middleware. The heuristic: "software ownership is worth 30–70x more than cheap power for long-run margins."

3. Hyperscaler capex as leading indicator Track Mag7 (MSFT, META, GOOGL, AMZN) capex guidance revisions. Upward revisions are a 1–3 quarter leading indicator for small Neocloud revenue acceleration. Serenity used META's $60–65B 2025 capex guide (reaffirmed in Oct earnings) and MSFT's Azure AI buildout as recurring confirmation signals for NBIS.

4. Tariff shock = buy signal, not risk-off Oct 10 tariff escalation prompted most traders to reduce tech exposure. Serenity's response was the opposite: used the -8% to -15% selloff across Neocloud names to add NBIS leaps at $98.8 (Oct 22), citing the thesis that hyperscaler capex is committed and does not respond to tariff cycles within a 12-month horizon.

5. Institutional accumulation via dark pool activity Serenity monitors unusual block trade flow as an early signal of institutional positioning. Cited repeated dark-pool accumulation in NBIS in Oct as evidence that large institutions were loading at sub-$100 levels before the Q3 catalyst. The inference rule: sustained block buying at discounted levels + compressed retail float = asymmetric setup.

6. Tax-loss harvesting window as entry opportunity Oct–Nov institutional selling pressure in YTD underperformers is not fundamental; it is mechanical. Serenity used this window specifically to add NBIS, CIFR, and IREN during Oct–Nov, knowing selling pressure would abate by Dec. Explicitly called out that NBIS trading at sub-$100 in Oct reflected tax-loss-harvesting dynamics, not a deteriorating thesis.

7. SPAC low-float mechanics for first 30 days For SPAC IPOs (specifically WLAC in this period), shares in the first 30 days trade at a structural premium due to low float. Warrants are the lower-risk entry but shares produce larger % returns if the name moves. Serenity sized small in WLAC shares at ~$12 for asymmetric upside.

8. Sum-of-parts cross-check on holding company discount For NBIS, Serenity ran a sub-asset cross-check: Clickhouse (28% stake, ~$4.3B private valuation implied), Avride (83% stake, autonomous delivery), Toloka (~65% stake, AI data labeling). The NBIS market cap at $12–13B in Oct traded at a discount to the sum-of-parts of subsidiaries plus core HPC business. Used this as a floor/support argument when adding.

9. Rate sensitivity as a covariate, not a driver With 2–3 Fed rate cuts expected in H2 2025 (later repriced in Nov), Serenity flagged high-beta growth names (NBIS, CRWV, RKLB) as rate-sensitive but not rate-dependent. The thesis holds at current rates; cuts are incremental multiple expansion, not a precondition. When Nov credit tightening repriced cuts lower, Serenity did not exit positions but acknowledged it as a near-term headwind.

10. CSP (cash-secured put) as swing entry at local bottoms Preferred option structure for adding exposure at local lows: sell CSPs at support strikes, collect premium as downside offset. Serenity explicitly mentioned using CSPs on NBIS and other Neocloud names at key support levels rather than buying stock outright, allowing for defined-risk entry with premium income while waiting for a catalyst.

11. News-narrative lag as edge Serenity's explicit stated edge: Twitter/X financial commentary is 1–3 days behind actual fundamental developments; institutional research is 2–4 weeks behind. The window to build a position before consensus is the gap between data release and narrative absorption. Used this framework for NBIS Q3 (positioned before earnings), SNAP (positioned before advertiser turnaround narrative developed), and FLY (positioned before leasing super-cycle narrative spread).

---

B. Per-ticker theses

NBIS (Nebius Group) — S-tier, highest conviction

• Core thesis: NBIS is the only publicly-traded full-stack GPU cloud provider with European-grade data sovereignty, sub-$100 price in Oct was a tax-loss-harvesting anomaly, not a fundamental signal. Core HPC revenue was doubling sequentially.
• Target: $400 per share 1-year bull case (stated Oct 17 and reiterated post-earnings Nov 11); $200 base case. Market cap implied at $400: ~$100B+ (comparable to mid-tier hyperscaler).
• Earnings catalyst (Nov 11): Q3 2025 blowout — $3B deal with META disclosed, $7–9B ARR guided for FY2026. GAAP gross margin 71.2%, described as "best in class" for public Neocloud. Stock reaction was positive but Serenity argued consensus still underestimates the margin trajectory.
• Subsidiary optionality: Clickhouse (~28% stake) valued at ~$4.3B implied; Avride (83%, autonomous delivery robotics); Toloka (~65%, AI data labeling). Sum-of-parts analysis suggested the subsidiary portfolio alone could justify $8–12B of NBIS's market cap, meaning the core HPC business was trading at a discount to peers.
• Key risk flagged: MSCI index inclusion timing — if NBIS is added to a major index, institutional inflow estimate is in the "hundreds of millions to low billions" range; if excluded or delayed, that demand disappears. Also flagged: execution risk on scaling GPU clusters past 10,000 H100s.
• Position size: Serenity disclosed $300K leaps added Oct 17, another $200K leaps Oct 22 at $98.8, and total NBIS exposure exceeding $2M+ by Oct 25. This is her largest disclosed single-stock position in the corpus.

CIFR (Cipher Mining) — A-tier

• Core thesis: High-quality bare-metal HPC operator with clean balance sheet, strong power procurement, attractive enterprise pricing for AI workloads. Not full-stack, so lower margin ceiling than NBIS, but better risk/reward than pure BTC miners at comparable valuation.
• Trade outcome: Sold Oct 25 after +250% gain from initial entry. Serenity explicitly booked the position and rotated proceeds into NBIS leaps. The exit was not thesis-abandonment; she flagged CIFR as still a good company but the easy money was made.
• Post-sale view: Maintained as A-tier in Nov Neocloud tier list; thesis intact, just harvested.

IREN (Iris Energy) — A-tier

• Core thesis: Good operator, strong Australian power relationships, expanding into HPC. However, margin disclosure is misleading — "92% gross margins" are hardware-specific non-GAAP, not comparable to full-stack margins.
• Key analytical event (Nov): IREN disclosed a new HPC deal. Serenity read the contract terms carefully and concluded the deal margin was lower than the headline implied because IREN was reselling capacity rather than owning the orchestration stack. Called it "a good deal but not transformative for margin profile."
• Position: Held as a diversification play alongside NBIS; smaller size. Not a conviction buy at the same level as NBIS.
• Tier list (Nov): A-tier alongside CIFR and WULF.

CRWV (CoreWeave) — F-tier (post-earnings)

• Pre-earnings view (Oct): Serenity was cautious — noted CRWV's revenue is largely committed-contract based (not spot), which reduces upside optionality, and that its balance sheet was more levered than NBIS.
• Post-earnings view (Nov): Downgraded to F-tier after earnings miss + credit tightening headlines. Specifically cited: contract concentration risk (1-2 hyperscaler customers = >60% revenue), rising cost of capital for GPU infrastructure debt, and opaque margin disclosure. Described the Nov crash as "warranted, not a buying opportunity at current valuation."
• Sector read-through: CRWV's issues are company-specific, not sector-wide. Used CRWV weakness to argue NBIS's superior balance sheet and margin profile deserved a larger valuation premium.

WLAC (WL Asset Corp) — SPAC thesis

• Thesis: Small SPAC with a niche logistics/supply-chain asset base. Low float in first 30 days creates asymmetric share price move potential. Serenity sized small (~$12 entry on shares) for a defined upside trade, not a long-term hold.
• Mechanics: First 30 days post-IPO, redemptions are constrained and float is thin. A modest amount of buying can move the stock 20–40%. Warrants are safer but less leveraged.
• Outcome: Flagged in Oct; no disclosed exit by end of Nov.

SNAP (Snap Inc.) — Contrarian recovery thesis

• Thesis (Oct): Advertiser budgets were rotating back from TikTok-risk platforms to Snap following TikTok regulatory uncertainty. Snap's 18–29 demographic is unique and not replicated on Instagram. Direct-response ad revenue was beginning to recover after 18 months of underperformance.
• Catalyst: Q3 earnings. Serenity positioned ahead of it.
• View: Medium conviction, not in the same weight class as NBIS. Used as a portfolio diversifier with different macro sensitivity.

FLY (Fly Leasing / Avolon context) — Aircraft leasing super-cycle

• Thesis: Post-COVID aircraft delivery delays created a multi-year leasing super-cycle. OEM delivery backlogs (Boeing and Airbus) mean airlines must lease at premium rates for 3–5 more years. FLY is a pure-play beneficiary with low valuation relative to book.
• Conviction: Medium. Serenity sized FLY as a sector diversifier, not a top-5 position. Mentioned it as an "uncorrelated compounder" — not correlated to AI/tech macro.
• Time horizon: 12–24 months for thesis to play out fully.

RKLB (Rocket Lab) — Launch cadence / space infrastructure

• Thesis: Neutron rocket development timeline is the key variable. If Neutron hits 2026 launch cadence, RKLB becomes the only credible SpaceX competitor in medium-lift. In the meantime, Electron launches provide cash flow visibility.
• Rate sensitivity: RKLB is high-beta and rate-sensitive. Nov credit tightening weighed on the stock. Serenity did not exit but acknowledged multiple compression risk.
• View: High conviction on the long-term thesis; tactical caution in Nov environment.

META (Meta Platforms) — Hyperscaler capex anchor

• Role in thesis: Not a standalone trade so much as the anchor confirmation for the entire Neocloud thesis. META's $60–65B 2025 capex guidance was the primary demand signal Serenity used to justify NBIS's revenue trajectory.
• Direct trade (Oct 30): Bought META calls ahead of Q3 earnings. META beat on revenue and reaffirmed capex; calls profitable.
• Ongoing: Treated as a liquid hedge/confirmation play alongside NBIS leaps.

MSFT (Microsoft) — Azure AI / hyperscaler confirmation

• Role: Secondary hyperscaler signal. Azure AI growth rates cited repeatedly as confirmation that enterprise AI workload demand is not softening. Not a direct position mentioned; used as macro framing.

NVDA (Nvidia) — Supply chain bottleneck, not a trade

• Thesis framing: NVDA is the GPU supply constraint for all Neoclouds. Serenity treats NVDA as a background variable — if NVDA supply loosens, Neocloud build-out accelerates; if it tightens further, existing operators benefit from pricing power.
• Nov analysis: Discussed TPU vs GPU competition. Key finding: Google's TPU v5 and Microsoft's MAIA chips are real alternatives for inference but not for training at frontier scale. NVDA's training monopoly is intact for 18–36 more months. Inference competition is a 2026–2027 story.
• Direct position: Not disclosed in Oct–Nov. NVDA treated as background infrastructure, not a primary trade.

TSM (TSMC) — Semiconductor supply chain

• Role: Cited as the fab constraint for advanced AI chips. TSMC's CoWoS packaging capacity is the physical bottleneck for H100/H200 production. Any TSMC capacity expansion announcement is bullish for GPU cloud names.
• No direct position disclosed in this period.

MU (Micron) — Memory cycle positioning

• Thesis (Oct): HBM (high-bandwidth memory) is in undersupply for AI training applications. Micron is 12–18 months behind Samsung and SK Hynix in HBM but is catching up fast. If Micron hits HBM3E volume in Q1 2026, the memory cycle has another leg.
• View: Opportunistic, not core. Serenity mentioned MU as a supply-chain beneficiary of AI capex but did not disclose a large position.

ALAB (Astera Labs) — Connectivity fabric for AI clusters

• Thesis: PCIe retimers and CXL switches are the hidden infrastructure of large GPU clusters. ALAB is the dominant supplier of PCIe retimers to hyperscaler GPU server racks. Revenue is directly tied to H100/H200 deployment volumes.
• View: High-quality niche operator, reasonable valuation given growth rate. Serenity mentioned it as a portfolio complement to NBIS — different risk profile, same demand driver.

CRDO (Credo Technology) — Optical connectivity

• Thesis: Active electrical cables (AECs) are replacing traditional DACs in 400G/800G data center interconnects. CRDO is gaining share from Amphenol and Molex. Revenue is hyperscaler-driven.
• Similar profile to ALAB — niche connectivity infrastructure, direct AI capex beneficiary.

AMD — GPU competitive positioning

• View (Nov): MI300X ramp is real but NVDA's software moat (CUDA ecosystem) is underappreciated by AMD bulls. AMD can win inference workloads at commodity pricing but training is still NVDA-dominant. Serenity's implication: don't bet on AMD displacing NVDA in the next 12 months, but AMD is a legitimate #2.
• No direct position disclosed.

HOOD (Robinhood) — Retail trading platform leverage on market activity

• Thesis: HOOD's revenue is correlated with retail trading volumes, options activity, and crypto. A risk-on environment in 2025 (rate cuts, AI enthusiasm, crypto rally) is directly accretive to HOOD's topline. Serenity mentioned HOOD as a "macro beta" trade — buy when you're bullish on retail participation.
• Oct view: Mentioned positively. No large position disclosed.

BTC / IBIT — Crypto as institutional asset class

• Thesis: Bitcoin ETF approval (IBIT) has structurally increased institutional access. Rate cuts and dollar weakness are near-term catalysts. LTC mentioned as a high-beta play if BTC makes a new ATH cycle.
• Mentioned in Oct as portfolio diversifier and as a signal of risk appetite. Not a primary position.

WULF (TeraWulf) — Bitcoin miner with HPC optionality

• Tier list (Nov): A-tier. Good power assets, early HPC transition, but bare-metal like CIFR/IREN. Margin ceiling lower than NBIS.
• No direct trade disclosed in Oct–Nov; monitored as a Neocloud diversification option.

SMCI (Super Micro Computer) — GPU server OEM

• Mentioned briefly in Oct in context of NBIS server infrastructure. Serenity noted SMCI's accounting issues (delayed 10-K) as a risk that could create supply chain disruption for GPU cluster deployments. Not a direct position.

AMZN (Amazon) — Hyperscaler / AWS

• Role: AWS capex confirms cloud demand signal alongside META/MSFT. Not a direct position in Oct–Nov; used as macro confirmation.

RDDT (Reddit) — Consumer platform, AI training data

• Mentioned in Oct in context of the AI data licensing story — Reddit's data deal structures with AI companies. Serenity was positive but did not disclose a position.

---

C. Thematic threads

Thread 1: The Neocloud Exodia thesis (Oct)

The central thesis of the Oct–Nov period. Serenity developed the concept of "Neocloud Exodia" — a set of five attributes that, when present in combination, create an asymmetric investment opportunity: 1. Full-stack GPU orchestration software (not just bare metal) 2. Signed hyperscaler contracts providing revenue visibility 3. GAAP gross margins >50% (distinguishes software-enriched from commodity compute) 4. Management team with prior enterprise software or hyperscaler experience 5. Sub-$20B market cap at time of identification (before institutional re-rating)

NBIS was the only public company hitting all five criteria in Oct 2025. CRWV hit 2/5 (contracts but no software moat, not GAAP-margined, over-levered). CIFR/WULF/IREN hit 1/5 (contracts but bare metal). This framework underpins Serenity's tiered conviction sizing.

Thread 2: Tariff shock as buying opportunity (Oct 10–12)

Oct 10: Major tariff escalation announcement. Neocloud and AI infrastructure names sold off 8–15% in a single session. Serenity's public call was to buy the dip, not reduce. Reasoning:

• Hyperscaler capex is committed 2–3 years in advance; tariffs do not affect contracted GPU deployments in the near term
• The selloff was driven by algorithmic risk-off, not fundamental re-rating
• Tax-loss harvesting was already suppressing these names; the tariff shock was additive to the discount

Oct 12: Serenity publicly named her "high conviction list" in order: NBIS, CIFR, IREN, META, RKLB, SNAP, FLY. She described the Oct 10 low as the "best entry point of 2025" for these names and indicated she was buying actively.

Thread 3: GAAP margin war (Oct–Nov)

A sustained analytical thread across both months centered on how to compare Neocloud margins across companies. Triggered by IREN's "92% gross margin" disclosure. Key points:

• Non-GAAP hardware-specific margins exclude SBC, depreciation of GPU assets, and G&A; GAAP margins include all of these
• IREN's GAAP gross margin is substantially lower than 92%
• NBIS's 71.2% GAAP gross margin (disclosed Nov 11) is the highest reported GAAP margin among all public Neocloud operators
• The conclusion: investors who compare non-GAAP margins across companies will systematically mis-rank these stocks; NBIS's quality is disguised because its disclosure is more honest

This thread was both an analytical argument and a market inefficiency thesis — if most investors are using non-GAAP comparisons, NBIS is systematically undervalued.

Thread 4: Institutional accumulation and MSCI inclusion (Oct)

Serenity tracked dark-pool and block trade activity in NBIS through Oct. Her inference: large institutions (she named "sovereign wealth and long-only" as the likely buyers) were accumulating at sub-$100 levels in anticipation of a potential MSCI index inclusion event. The mechanics:

• NBIS is eligible for MSCI EM or MSCI ACWI inclusion based on float and market cap thresholds
• Inclusion would trigger passive flows from index-tracking funds
• Estimated inflow on inclusion: hundreds of millions to low billions (small vs. NBIS's float but meaningful)
• Institutions pre-position before inclusion announcement, not after

This provided a near-term catalyst pathway separate from the fundamental thesis.

Thread 5: November credit tightening and sector triage (Nov)

A major Nov thematic: credit tightening re-priced rate cut expectations, causing multiple compression in high-beta growth names. CRWV was the most visible casualty (F-tier post-earnings). Serenity's response was triage:

• Downgraded CRWV to F-tier (contract concentration + leverage + opaque margins = bad in a tight credit environment)
• Maintained NBIS as S-tier (strong balance sheet, high GAAP margins, no leverage overhang)
• Slightly reduced IREN (good operator but dependent on new deals for margin improvement)
• Reaffirmed CIFR and WULF as A-tier (solid power assets, manageable leverage)

The analytical distinction: credit tightening hurts levered operators and growth-story valuations; it is neutral-to-positive for operators with actual GAAP earnings power. NBIS's 71.2% GAAP gross margin means it can self-fund growth even if external capital gets more expensive.

Thread 6: NBIS subsidiary optionality as unlocked value (Nov)

Post-Q3 earnings (Nov 11), Serenity pivoted attention to NBIS's subsidiary portfolio as an underappreciated source of value:

• Clickhouse (database software, 28% NBIS stake): Valued at ~$4.3B implied from private rounds. Comparable to Snowflake at similar growth rates. If Clickhouse IPOs or gets acquired, NBIS captures hundreds of millions in gain.
• Avride (83% NBIS stake): Autonomous delivery robotics. Pre-revenue but Serenity argued the robotics sector re-rating (post-Tesla Optimus, post-Figure AI) would lift Avride's valuation in any 2026 funding round.
• Toloka (~65% NBIS stake): AI data labeling. Direct beneficiary of LLM training demand. Revenue-generating, growing. Comparable to Scale AI but at a fraction of Scale's implied valuation.

Sum-of-parts implication: core HPC business at $12–13B market cap in Oct was trading below fair value even before subsidiaries.

Thread 7: TPU / GPU competition and NVDA's training moat (Nov)

Serenity analyzed Google's TPU v5 and Microsoft MAIA as competitive threats to NVDA. Conclusions:

• Training at frontier model scale: NVDA H100/H200 remain dominant for 18–36 months. CUDA ecosystem switching costs are too high.
• Inference: TPU v5 and MAIA are cost-competitive for inference-only workloads. This will gradually erode NVDA's inference revenue share.
• For Neoclouds: the risk is inference commoditization, not training. NBIS's workloads are currently weighted toward training and enterprise custom fine-tuning, which protects margins.
• Implication for NBIS: 18-month window before inference pricing pressure arrives; use this window to cement enterprise relationships.

---

D. Dated calls (track-record timeline)

Misc dated observations (Oct):

• Oct (early): SNAP positioned ahead of Q3 earnings; thesis = TikTok-risk advertiser rotation + unique 18-29 demographic
• Oct (early): FLY mentioned as aircraft leasing super-cycle play; OEM delivery delays = 3–5 year tailwind
• Oct (early): SPRB (Spruce Biosciences) mentioned as a small biotech trade; non-core, one-off
• Oct (mid): BTC/IBIT mentioned as portfolio diversifier and risk-appetite signal; LTC as high-beta if BTC ATH cycle
• Oct (mid): RDDT mentioned positively in context of AI data licensing story
• Oct (late): SMCI flagged as risk factor for GPU server supply chain due to delayed 10-K filing

Nov macro timeline:

• Nov 11: NBIS Q3 earnings blowout — sector catalyst; NBIS gaps up
• Nov (mid): Credit tightening and rate-cut repricing — sector headwind begins
• Nov (mid): CRWV earnings miss — sector overhang on Neocloud names
• Nov (late): Serenity's response = hold NBIS, triage the rest; credit-tightening environment favors GAAP-profitability operators over levered growth stories

---

Generated from: 2025-10.txt (490 tweets) + 2025-11.txt (339 tweets) Methodology: full-corpus read, no sampling

Analysis: 2025-12 to 2026-01

A. Methodology signals

Supply-chain signal hunting — "who is the real bottleneck"

• His primary edge is multi-hop supply-chain mapping: he traces a hyperscaler program (e.g., Google TPU v7) all the way down to raw-material producers, then asks "what is the single point of failure?" Examples: photonics → InP substrates → laser-grade InP feedstock; humanoid robots → structural frames → Germanium glass for thermal seekers.
• He explicitly labels each layer: Tier 1 customer-facing companies (LITE, COHR, MRVL), Tier 2 material/substrate producers (AXTI, Sumitomo), Tier 3 feedstock miners/refiners (Vital Materials, DOWA).
• He tracks capacity signals from earnings calls: "CEO [COHR Q3 ER] said 'supply-constrained by InP lasers'" (2025-12-27); "COHR CEO maxed out capacity" (2026-01-09). Lead-time data and commodity price feeds (Shanghai Metal Market, Indium Corporation) are cited as live checks.
• BOM analysis is a core tool. He estimates percentage of cluster spend that flows to a given supplier (e.g., "$LITE captures ~8–12% of Google TPU cluster BOM"; "$AXTI = $100 substrate in a $20B TPU deployment"; a 3000% price increase would be a rounding error to a hyperscaler) to argue TAM is vastly understated.
• Catchphrase: "buying into the bottleneck" — used for HBM memory, InP substrates, Germanium glass, and InP feedstock. He compares each new bottleneck to prior historical precedents (Neon gas 2022: +2000%; Dysprosium 2010: +2300%; HBM 2024–25: SK Hynix/MU).
• He distinguishes "quantity" (how much supply) from "price" (monopoly pricing power): "You don't need to produce 3000% more material… just increase the prices" (2026-01-09). He calls this "game theory allocation wars."
• He uses "first seen on X" as a signal for conviction: posts early theses before institutional coverage then cites analyst notes (Craig-Hallum, Mizuho, JP Morgan, UBS) as "lagging validation."

Orders, contracts, and capacity signals

• He reads new contracts for sector-level implications: HUT $7B / 15-year deal with Anthropic via Fluidstack (2025-12-17); IREN $MSFT deal; NBIS $META $3B + $MSFT ~$19B over 5 years. He focuses on the tenant's creditworthiness — e.g., ORCL/CRWV are problematic because their main tenant (OpenAI) lacks the FCF to fund its obligations.
• He checks revenue recognition timing vs. news date: when AXTI reported lower Q4 revenue (2026-01-08), he dismissed it as "2024 contracted backlog with 1Q deferral, not forward guidance."
• Government/DoD funding is a separate catalyst he tracks — SPEED Act (DC permitting reform, 2025-12-17), Trump EO to seize HieFo InP assets (2026-01-17), $1.5T DoD budget as tail for defense stocks.

Conviction formation and position sizing

• High conviction = "fundamentally de-risked" (Mag7 counterparty + locked 5-year take-or-pay contracts). He differentiates NBIS/IREN (MSFT/META backstop) from ORCL/CRWV (OpenAI counterparty risk) explicitly.
• He uses a "high-conviction basket" (NBIS, RKLB, ALAB, CRCL, LITE — announced 2025-12-20) vs. a "short-to-medium term swing" bucket (SMCI, SNAP, CRDO, TTD, etc.).
• Risk management: smaller position sizes on microcaps with execution risk (AAOI: "small-moderate position sizing"); uses calls instead of shares for extreme-risk names where China export ban could go to zero (AXTI: "Calls are actually safer than shares" 2025-12-30).
• He explicitly prices macro overlays: yen carry-trade unwind from BOJ hike + Fed cut = short-term headwind regardless of fundamentals (2025-12-08, 2025-12-17). He accepts that short-term pressure is not thesis-breaking.
• Catchphrase: "If the only thing that's changed is the stock price and not the thesis, give it time to play out" (2025-12-15).
• He tracks institutional ownership changes as a conviction check: NBIS institutional ownership rose from ~38% to ~52%+ between Sept and Dec 2025 as retail capitulated.

Risk and timing vocabulary

• "Prove It" phase — Neoclouds need to show margins at scale (2025-12-30).
• "Utilization lag" — GPU depreciation clock starts before revenue flows; SPEED Act as a fix.
• "ATM overhang" — active at-the-money share sales drag stock prices independent of fundamentals (NBIS $2B ATM, IREN dilution).
• He uses "FinX bubble" as a contrarian bullish signal: retail is directionally right but wrong on timing (TSM $150 → $300+; MU $65 → $245; HOOD $18 → $100+).
• He uses historical mispricing events as a pattern: "ticker collision" (VLN NYSE vs VLN.TO), "fake news" (CRDO cable color change), "analyst disinformation" (Benchmark on MRVL/Alchip).

---

B. Per-ticker theses

$NBIS — AI Neocloud + Robotaxi + multi-subsidiary holding company

• Stance: Extremely high conviction long. Core portfolio, held through full Dec selloff. "Highest asymmetrical upside possible."
• Thesis: Nebius is 5 companies in 1: (1) AI DC neocloud scaling to $7–9B ARR 2026 at 20–30% EBIT margins; (2) Avride — FSD Level-4 robotaxi, now live in Texas with Uber; (3) Clickhouse — DB used by Tesla, Meta, Netflix, Tiktok; (4) Toloka/Tripleten — AI labeling (Toloka) + ed-tech (Tripleten), growing 100%+ Y/Y each. Markets don't associate Avride with Nebius (e.g., Uber gained $6B MC on Avride launch, NBIS dropped 3%). Hedgeye short "NBIS is Coreweave 2.0" refuted point-by-point on Dec 5.
• Evidence/catalysts cited (dated):
• MSFT deal (~$19B / 5-year, take-or-pay) + META $3B deal (announced before Dec period)
• MSCI inclusion inflows (Dec 2025)
• Avride Uber Texas commercial launch (2025-12-03)
• Dan Ives / Wedbush: "likely acquisition target by GOOGL/MSFT/AMZN in 2026" (2025-12-19)
• Institutional ownership: ~38% → ~52%+ by Dec 2025
• Convertible notes at ~2% interest ($73M/year) vs CRWV $1.3B/year
• $4.8B+ cash on balance sheet
• Calls/targets/entries-exits (dated):
• "Extremely strong buy at $130" (Nov / pre-period); still buying at $125; added at various Dec lows
• "NBIS easily blows past $250 once management projections achieved in 2026" (2025-12-21)
• $12/19 $130C options cited as example position (2025-12-09)
• Held through $140 → $79 drop; "trading like a distressed asset" (2025-12-15)
• Stance changes: No change in fundamental stance. Acknowledged ATM dilution as a "pain" but not thesis-breaking. Frustrated by Hedgeye short (2025-12-05) and ORCL contagion selloff (2025-12-11).

$AXTI — InP substrate/feedstock critical materials; "bottleneck within a bottleneck"

• Stance: Extremely high conviction long (introduced mid-late Dec 2025, became dominant theme by Jan 2026). "Buying into the bottleneck."
• Thesis: AXTI (Beijing Tongmei Xtal Technology) controls ~40% of the global InP supply chain (CEO's own words on earnings call). As AI buildout shifts from copper to photonics, InP substrates are the critical material for every EML laser, optical transceiver, and OCS switch. The duopoly was AXTI + Sumitomo (~60–70% of InP substrates). After China's Jan 6 2026 export control ban on Japan (dual-use items to Japanese defense-adjacent companies), Sumitomo and JX face feedstock starvation in ~3–6 months, making AXTI effectively a monopoly. $700M–$1.3B MC controls the single point of failure for Nvidia ($4.6T), MSFT ($3.59T), GOOGL ($3.89T), META ($1.64T), and AMZN ($2.57T).
• Evidence/catalysts cited (dated):
• 2025-12-26: Identified InP substrate duopoly; AXTI CEO quote on 40% of supply chain
• 2025-12-27: Deep-dive on "bottleneck within a bottleneck" — Vital Materials controls ~35% of InP polycrystal feedstock; AXTI ~25% (captive + merchant); 78% of laser-grade feedstock in China
• 2025-12-30: Indium prices: 7N grade spiked from ~$1,150/kg (Jan 2024) to $3,450+/kg (Dec 2025); Western markets paying 200%+ premium over SMM
• 2026-01-02: Northland Capital $100M raise by AXTI to fund capacity expansion; China announced 1-year suspension of gallium/germanium ban on US until Nov 27 2026 (runway for AXTI)
• 2026-01-06: China Commerce Ministry announces dual-use export ban on Japan; Sumitomo/JX now face feedstock starvation; AXTI becomes effective monopoly. AXTI +14% that day.
• 2026-01-06 (evening): Jensen Huang says "memory bottleneck is severe"; Serenity posts that InP will be the next bottleneck
• 2026-01-08: AXTI AH -29.54% on Q4 revenue miss ($23M vs $27–30M) — he dismisses as "deferred 2024 contracts, not forward guidance"; stands firm
• 2026-01-08: 7N Indium hits ATH on SMM ($812–$901/kg); Western market prices are a "large premium" on top
• 2026-01-12: Craig-Hallum re-rates AXTI to Buy, $26 PT (+160%), citing "trifecta of dynamics"
• 2026-01-17: Trump EO to seize HieFo/Emcore InP assets — "US gov now treating InP as national security emergency" — further validates thesis
• LightCounting data: demand for 800G transceivers exceeds supply by ~2x
• McKinsey: 40–60% shortfall for 800G modules; 30–40% shortfall for 1.6T modules
• Calls/targets/entries-exits (dated):
• Initial position mentioned ~Dec 26–29 2025; held through Jan 2026
• "Up 78% since posting and 20% today" (2026-01-15)
• "Up 60%" in week of Jan 14 2026
• Used longest-dated calls available as China export risk means shares could go to zero ("calls are actually safer than shares")
• No specific PT given; "impossible to model… TAM could go from few hundred million to $10B+ in extreme scenario"
• Stance changes: None. Doubled down after AH selloff on Jan 8 2026.

$LITE (Lumentum) — Optical Circuit Switching monopoly; Google TPU v7 / all ASICs

• Stance: High conviction long, then reduced to "Buy" (sold positions around $385 in early Jan 2026; moved to "COHR more liked").
• Thesis: LITE is in every major hyperscaler chip deployment: TPU v7 (OCS monopoly, 8–12% BOM share), NVDA Blackwell (~2–3% BOM share split), AMZN Trainium, MSFT Maia. OCS architecture (Google-unique) means LITE takes the largest optical BOM share. "316% YTD, might be 1000%+ by 2027" (2025-12-22).
• Evidence/catalysts cited (dated):
• 2025-12-01: Initiated position after TPU v7 supply chain analysis; entered at ~$316.5
• 2025-12-08: Updated to ~$335.91 (+5.53%)
• 2025-12-11: New catalyst: AMZN $10B OpenAI funding + adoption of Trainium ASICs
• 2025-12-22: Full thesis post: "$40B Google TPU spend by 2027; LITE captures 10% = $1.5B+ FCF from Google alone, 17x earnings from just primary customer"
• 2025-12-23: AAOI up 24%, LITE up 5% "since thesis" — same day
• Supply constraint from InP substrate shortage noted: "NVDA monopolized EML capacity from COHR and LITE" (2026-01-02)
• AVGO earnings miss (2025-12-12): LITE -12.23%, he called it a buying opportunity
• Calls/targets/entries-exits (dated):
• Entry: ~$316.5 (2025-12-01); updated ~$335.91 (2025-12-08)
• "Overextended" commentary at ATHs; "a tad overextended" (2025-12-08)
• Sold LITE positions at ~$385 (2026-01-06) — "I did some internal research and found some potential issues but didn't publish it yet"
• "Still a good long but not as high conviction as NBIS" (2026-01-06)
• Stance changes: Downgraded from high-conviction to Buy / reduced position in early Jan 2026 after InP supply chain vulnerability discovered (second-order risk: if Sumitomo runs out of feedstock, LITE faces capacity shortfall).

$AAOI (Applied Optoelectronics) — MSFT Maia + AMZN Trainium optical play

• Stance: Bull, but not high conviction. "Small-moderate position for risk management."
• Thesis: AAOI is a levered call on MSFT Maia 300 and AMZN Trainium ramp. Only InP fab in the US (vertically integrated with Texas fab). Direct warrant/purchase agreement with AMZN (~$4B). "Only up 2.9% YTD despite new hyperscaler orders." Likely co-developing new optical interconnect architecture for MSFT. "$2.5B MC is a fraction of MRVL and LITE."
• Evidence/catalysts cited (dated):
• 2025-12-11: Initiated position after AMZN Trainium supply chain research
• 2025-12-23: AAOI +24% day of first LITE/AAOI thesis post
• UBS note (est. 1M+ Maia chips by 2027): $3–4B optical BOM; AAOI capturing 20–30% = $600M–$900M triple+ ARR
• 2026-01-07: MSFT lowered Maia estimates; AAOI "heavily tethered to MSFT Maia"; held but acknowledges "wait it out for a year or two"
• Maia 300 chip production target: 300–400K units late 2026 → 1.2–1.5M units 2027 (Fubon Research)
• Calls/targets/entries-exits (dated):
• Small position, not a core holding
• Reduced photonic exposure (including AAOI) after Japan export controls (2026-01-09): "I sold my other photonic positions short term because Sumitomo got export controlled… second order effect on AAOI capacity"
• Still holds medium-term thesis: "more of an inevitability minus execution uncertainty"

$MRVL (Marvell Technology) — MSFT Maia 300 primary design partner

• Stance: Strong buy (end-Dec 2025, Jan 2026). Core thesis on Maia ramp.
• Thesis: UBS/Fubon est. Maia 300 revenue = $10–$12B to MRVL in 2027 — double their FY2025 revenue. Benchmark downgrade claim that AMZN lost Trainium 3/4 to Alchip was disinformation; Benchmark walked it back quietly (Dec 23 2025). The Information "Microsoft negotiating with Broadcom" article is "sensational journalism" — physics of mid-cycle chip swap is impossible (30–38 month timeline). JP Morgan confirmed no ASIC program share loss.
• Evidence/catalysts cited (dated):
• 2025-12-08: Benchmark "high conviction" downgrade → stock -14%; Dec 23: Benchmark retracted
• 2025-12-09: MRVL CEO on CNBC: "We didn't lose any business"
• 2025-12-31: Full analysis post; "MRVL looks like extremely solid long, 2026–2027 forecasts light because MSFT/AMZN delayed ramp, but orders in hand"
• PT modeled: "From forward $20B revenue, 30x P/E = $231.60/share from $85 if you wait 2 years"
• 2026-01-07: Added CRDO on 25.7% drop citing CES misinformation
• Jan 1 ratings: MRVL listed as "Buy"
• Calls/targets/entries-exits (dated):
• January 1 2026 "Buy" rating; "down 23% YTD" — recovery play
• No specific entry price cited

$CRCL (Circle) — Stablecoin issuer / private-sector Federal Reserve

• Stance: Extremely high conviction long, added to core basket (2025-12-20/21). "1000%+ thesis."
• Thesis: Circle is "the private-sector extension of the US Treasury." USDC has captured the network effect for institutional US markets (Visa, Stripe, Banks) — Tether owns international grey-market, USDC owns regulated institutional. Business model: print USDC → buy US Treasuries → collect 5% risk-free → effectively infinite margins. Float dynamics caused 70% drop from $250 IPO high to ~$84 (float unlock + rate cuts). Network effect moat: hundreds of stablecoins exist but USDC is the settlement standard. $18B MC for "de facto private-sector CBDC."
• Evidence/catalysts cited (dated):
• 2025-12-21: Full thesis post at $84 (~$18B MC); bought on drop from $250 IPO high
• "GENIUS Act" making Circle pursue bank charters = connection to Federal Reserve system
• 50% USDC revenue split with COIN (viewed as contract renegotiation risk by 2027)
• "I help SV VC firms with DD — record amounts of USDC-related fintech investment flowing in"
• Bought Circle on drop to $70 (late Dec 2025)
• Jan 1 2026: "Strong Buy" in ratings
• Calls/targets/entries-exits (dated):
• Entered at ~$70–$84 (Dec 2025)
• "Circle deserves to be a $50B+ company" (conservative case)
• "100%+ upside going into 2026 – early 2027"

$SMCI (Super Micro Computer) — GPU server value play

• Stance: "Extremely strong buy" (rated as such explicitly in Nov; still bullish Dec); swing trade / short-medium term.
• Thesis: Growing 60%+ Y/Y forward revenue but trading at ~11x forward P/E. Revenue "delay" (Q1→Q2 shift from Blackwell spec upgrades) misread by market as revenue loss. Price: ~$32–33 when thesis reiterated (Dec). "The 40% drop for quarter backlog delay was unwarranted."
• Evidence/catalysts cited (dated):
• 2025-12-08: "SMCI ~$32.92 (+5.97%)" update
• Jan 1 2026: "Strong Buy" in ratings; "$17B valuation for less than .5x P/S"
• Goldman Sachs analyst report calling margin pressure permanent: Serenity disagrees — "margins expand over time with DLC cycles at scale"
• 2026-01-13: Added at $28.3; "swing trading it"
• Calls/targets/entries-exits (dated):
• Entry at ~$32–33 (Dec 2025); added at $28.3 (Jan 13 2026)
• "Fair value $48–55 range" on TTD; SMCI: ~$36B FY26 revenue = 60%+ growth mispriced at 0.5 P/S

$TSM (Taiwan Semiconductor) — AI buildout backbone

• Stance: High conviction long compounder; "safest one for compounding."
• Thesis: "Backbone of the whole AI/semi buildout. TPU vs GPU war doesn't matter — TSM doesn't care." Maxed capacity, increasing margins, multiple expansion as US builds out TSMC Arizona.
• Evidence/catalysts cited (dated):
• 2025-12-09: Added heavily at ~$302.5 ("record-breaking earnings, felt it would breakout anytime")
• Jan 1 2026: "Strong Buy"
• 2026-01-17: "TSM is $1.5T; INTC is $234B — 7x return just for waiting"
• Calls/targets/entries-exits (dated):
• Entered at ~$302.5 (2025-12-09)
• "One of the safest compounders next few years"

$RKLB (Rocket Lab) — Space / SpaceX #2 thesis

• Stance: High conviction long; "probably my favorite long." Acknowledged overvalued short-term but can't help it.
• Thesis: "SpaceX just got valued at $800B from $350B. Rocketlab will grow into SpaceX's prev valuation from $26B — it's just a matter of time." Same model as NBIS Avride → Waymo. Parallel: $RKLB at $15 → $50+ proves "directionally right, early" thesis works.
• Evidence/catalysts cited (dated):
• 2025-12-06: "$RKLB = $NBIS Avride" — both are #2 players in giant markets being mispriced
• SpaceX $1.5T valuation catalyst for sector (Dec 2025)
• Jan 1 2026: "Buy" (noted overvalued but still long)
• Calls/targets/entries-exits (dated):
• Core long; "can see Rocketlab at $300B valuation... one day"
• "Overvalued right now but can't help it due to SpaceX fomo" (Dec 10)

$IREN — AI Neocloud (GPU cloud / data center)

• Stance: Cautious / conditional buy. Held despite concerns. "Highest possible upside, biggest risk of them all."
• Thesis: $MSFT deal ($5.8B+ hardware commitment, prepayment but still huge dilution) validated the colo business. However, decision to buy GPUs for AI cloud (instead of pure colo) creates massive dilution risk to monetize 3GW pipeline. "I would not put money into this if they kept buying GPUs." MSCI not included (unlike NBIS). Has MSFT contract backstop so OpenAI contagion doesn't directly hit.
• Evidence/catalysts cited (dated):
• 2025-12-04: Concern on $2M/MW expedited costs for MSFT buildout
• 2025-12-15: "Never thought I'd see IREN at $35 again" — now lower than pre-Mag7 contract prices
• Jan 1 2026: "Strong Buy" (deeply oversold)
• Calls/targets/entries-exits (dated):
• Sold around $50–60 earlier (2025-12-12 mention); regret not entering at lower levels
• "Bag holding NBIS and IREN" (Dec 15)
• Short-dated put referenced: "$31 SMCI Put 12/12 seems pretty solid" (contextual aside on IREN at $40)

$AVGO (Broadcom) — Hyperscaler ASIC design / TPU ecosystem

• Stance: Long, "Buy."
• Thesis: Co-designs GOOGL TPU ASICs; central to hyperscaler custom silicon ecosystem. AVGO Dec earnings -11.64% was a buying opportunity — $73B backlog is "minimum contractual floor" not a cap; markets misread it as disappointing. Future competition for MRVL in Maia is a multi-year discussion, not immediate.
• Evidence/catalysts cited (dated):
• 2025-12-12: AVGO ER: $18.02B revenue (+28% YoY), beat, but -11.64% drop; bought the dip
• "$73B AI backlog for next 18 months" — Serenity believes front-loaded conversion should give $55–60B+ in 2026

$ALAB (Astera Labs) — AI connectivity

• Stance: High conviction long (original core basket).
• Thesis: "Higher margins than NVDA, growing triple digits Y/Y." Amazon equity agreement. Critical for DC interconnect.
• Evidence/catalysts cited (dated):
• 2025-12-09: "Amazing buy" at ~$250 down from high
• Dec 11: Entered at $250 as part of photonics / connectivity basket

$CRDO (Credo Technology) — Copper connectivity / AEC

• Stance: Bull (swing trade). Added on 25.7% drop, Jan 7 2026.
• Thesis: 272% Y/Y growth, beat earnings by 35%. Two drops were from misinformation: (1) AMZN cable color change (logistics request, not customer loss — confirmed by Mizuho's Vijay Rakesh); (2) Jensen "cableless" CES claim referred to internal rack NVLink, not Credo's external AEC product. "Markets are stupid — they traded off kindergarten logic."
• Evidence/catalysts cited (dated):
• 2026-01-07: Added at ~$130 after 25.7% drop; "dropped from $210 → $130 post-earnings from fake news"
• 2026-01-11: CRDO +15.47% recovery; "billions wiped just because AMZN doesn't like Purple"
• Calls/targets/entries-exits (dated):
• Entry ~$130 (2026-01-07); partial trade, not a core conviction hold

$LPTH (Lightpath Technologies) — Germanium glass alternative; defense bottleneck

• Stance: Extremely high conviction long, initiated 2026-01-14. "My favorite long of 2026."
• Thesis: Lightpath holds the exclusive US Naval Research Lab license for "Black Diamond" — a Chalcogenide glass that replaces Germanium glass (70% controlled by China, now export-banned for US military). Every Lockheed Stinger missile, Anduril Ghost drone, $ONDS Iron Drone Raider, L3Harris Arleigh Burke destroyer, UMAC attack drones use LPTH as "sole source" for optical/thermal assemblies. No second source. The 4-year gap until Korea Zinc refinery in Tennessee comes online (2030) means LPTH is structurally critical through 2029. "Not just important — Lightpath is a critical point of failure for the US Dept of War."
• Evidence/catalysts cited (dated):
• 2026-01-14: Initiated position at ~$621M MC; thesis published; stock up 25% same day
• 2026-01-15: "+25% since yesterday" — still holding; "$10B+ MC possible"
• Backlog: ~$90M+; "Sold out. Expanding margins."
• FY2025 revenue ~$37.2M → est. FY2026 ~$61.6M; margins expanding from ~27% to 35–40%
• Jan 18: Deep Germanium supply chain analysis; Germanium price tripled to ~$4,150/kg; "US has zero domestic refining capacity until 2030"
• Calls/targets/entries-exits (dated):
• Entry ~$621M MC (Jan 14 2026)
• "Easily see this being a $10B+ company down the road" (Jan 14)
• "Safer than AXTI since it's US supply chain this time" (Jan 14)

$VLN (Valens Semiconductor) — Robotics / automotive chipmaker; mispricing thesis

• Stance: High conviction long, initiated Jan 9 2026. "Holding 1 year for LTCG."
• Thesis: Purely a market-efficiency arbitrage discovery. Analyst/algorithm reports erroneously stated VLN had $82M in inventory (impossible given $136.7M total assets and $93.5M cash). Ticker collision with VLN.TO (Velan Inc., Canadian valve manufacturer). True inventory = $11M. The data error caused algorithms to model <1Y runway, heavily short the stock, and suppress it to ~1:1 with cash/assets. Actual business: fabless AI semi, $80M+ forward revenue, 69.1% gross margins (robotics segment), 63% blended, $93.5M cash, zero debt. Growing 40%+ Y/Y in robotics. Similar companies (Lattice, MACOM) trade at 14–18x EV/Revenue; VLN trades at 2.4x.
• Evidence/catalysts cited (dated):
• 2026-01-09: Discovered and published thesis; stock +58% on Friday
• 2026-01-09–12: Multiple posts defending against "pump and dump" allegations; emphasized Stonegate/Streetwise data error and manual cross-check
• Customers: Mercedes, Samsung, Mobileye, Siemens, Logitech, RGo Robotics
• Fair value model: "~$7.30 from forward 2027, $130M 5x EV/Sales + $93.5M net cash"
• Craig-Hallum PT for AXTI (separately) as "step-ladder" validation model
• Calls/targets/entries-exits (dated):
• Entry ~$1.50–$2.28 (Jan 9 2026)
• "Modeled ~$700M fair value = ~$6.50 per share" (vs ~$2.50 entry)
• Still up ~60% as of Jan 14 2026 — holding for 1Y LTCG

$OSS (One Stop Systems) — DoD edge AI / defense contractor

• Stance: High conviction long, initiated Jan 7 2026.
• Thesis: Combat-validated DoD edge AI contractor at $155M MC. Venezuela invasion revealed OSS involvement: P-8A Poseidon used OSS "Rugged Data Units" (from $5M urgent order July 2025); SOCOM "Ghost Fleet" uses OSS Rigel Edge Supercomputer for drone boats; Aegis warship systems. 45.6% gross margins (defense pure-play, after Bressner sale). Demand outstripping supply 2.4:1. "$41M cash / $155M MC — low downside risk." Previously missed because blended margins with commodity Bressner segment made margins look low.
• Evidence/catalysts cited (dated):
• 2026-01-07: Initiated; stock up 50%+ by Jan 8
• 2026-01-05: Venezuela invasion gave the catalyst for OSS usage discovery
• $1.5T DoD budget as secular tailwind
• Calls/targets/entries-exits (dated):
• Entry ~$155M MC (Jan 7 2026)
• "Wouldn't be surprised if at $1B MC in 6 months if the award goes through" (Jan 7)

$AIRO (Airo Group) — Counter-drone / interceptor drones

• Stance: Bull, initiated early Jan 2026.
• Thesis: "Bullet drone" intercepts other drones. Central to Pentagon "Replicator" program. NATO + Ukraine armed forces order for RQ-35 Heidrun. Trading at ~2.5–3x fwd P/S vs peers at 30–40x. Revenue "miss" in Q3 2025 ($6.3M vs. higher expectations) was deferred revenue, not lost. Net cash ~$68.8M on $250M MC. EV/Revenue at 2.1x vs AVAV at 9.4x.
• Evidence/catalysts cited (dated):
• Jan 1 2026: Mentioned as "Strong Buy"
• 2026-01-06: "Up 23% since post 3 days ago" — took position
• 2026-01-08: "Up 50%+ in a week"
• 2026-01-16: "Up 76.07%; hasn't had more than 1 red day since original posts"
• Calls/targets/entries-exits (dated):
• Entry early Jan 2026 (~$250–300M MC)
• "Holding until EOY in 10x potential basket"

$SSYS (Stratasys) — Humanoid robot frame / 3D printing materials

• Stance: Bull, initiated Jan 15–16 2026.
• Thesis: Stratasys Nylon 12CF (carbon fiber) is the structural frame/skeleton for Atlas, Optimus, Figure, and other humanoids. OpenAI robotics push on Jan 15 = catalyst. "Effective US certification monopoly" for humanoid frames given America-first policies vs Bambu etc. Revenue ramp depends on robotics scale-up; "this is more of a bet on the future of robotics." More than 1/4 cash, no debt = lower downside.
• Evidence/catalysts cited (dated):
• 2026-01-15: Thesis posted; OpenAI robotics push as catalyst
• Atlas switched from hydraulics to electric + lightweight Stratasys frames in 2024–25
• Politician "Debbie" bought SSYS early (insider signal note, Jan 15)
• 2026-01-16: Full robotics supply chain BOM post

$INTC (Intel) — US government foundry play

• Stance: High conviction long (Jan 2026). "One of my biggest positions."
• Thesis: Intel is "the de facto semi arm of the US government for national security." Trump/Apple/Nvidia pressure to use Intel wherever possible. At $234B MC vs TSM $1.5T — "7x return just for waiting." CHIPS Act + political mandate caps downside risk from cash-burning foundry. "I strongly believe Intel is one of the rare opportunities where you can invest in the White House."
• Evidence/catalysts cited (dated):
• Jan 1 2026: "Strong Buy" (from distressed)
• 2026-01-13: "Not degenerate at all to see that reality" — defending the Intel thesis against bearish analyst
• 2026-01-14: Trump interview leak: "Apple went in, Nvidia went in" on Intel investment
• 2026-01-17: Full thesis post; "$234B MC ($TSM is $1.5T), ~7x return just for waiting"

$CIFR (Cipher Mining) — Neocloud colo / BTC / GOOGL backstop

• Stance: "Safest one in the neocloud sector."
• Thesis: Backstopped by AMZN + GOOGL (via Fluidstack). Large Bitcoin on balance sheet for next halving. Colo model = no GPU depreciation risk. Short-term drag from BTC price but fundamentally de-risked.
• Evidence/catalysts cited (dated):
• CIFR dropped from $24 → $14 with ORCL contagion (Dec 2025); called buying opportunity
• Jan 1 2026: "Strong Buy"

$META — Earnings accounting optics trade

• Stance: Opportunistic long, added Jan 13 2026.
• Thesis: BBB (Big Beautiful Bill) one-time accounting reduced Q3 reported EPS to $2.71 vs. true net income $18.6B. "This works in reverse with optics when people see 700%+ q/q income growth when they don't do tax normalization." Historical analog: GOOGL long at $145 when "search is dying" narrative. Forward P/E 18.9x on 26% Y/Y growth = undervalued vs WMT at 40x on inflation-level growth.
• Evidence/catalysts cited (dated):
• 2026-01-13: Entered at $625; "screaming buy"

$SNAP (Snapchat) — FCF re-rate / undervalued

• Stance: Bull (Dec 2025 through Jan 2026); swing trade.
• Thesis: Perplexity deal adding $400M in equity/cash. Memory monetization (GCP opex cuts from 9GB "hotdog videos" → revenue stream). Net FCF estimate: +$630M from opex cloud cuts (+$190M), memory revenue (+$540M), storage COGS (-$100M). "100%+ upside going into 2026 – early 2027."
• Evidence/catalysts cited (dated):
• 2025-12-12: Full thesis post at $7.64 (~$13B MC); "EOY tax harvesting ending in 2 weeks"
• 2025-12-14: "Memory adoption rate probably single low digit at best" — nuanced on monetization speed
• Jan 1 2026: "Buy"

$TTD (The Trade Desk) — Value recovery

• Stance: Buy, swing trade.
• Thesis: "Complete valuation reset dropping 67% YTD." DCF: $735M FCF, 12% Y/Y growth → fair value $48–55. "78.1% gross margins, ~$2.9B FY revenue, 18% y/y growth, 95% customer retention, $1B in buybacks."
• Evidence/catalysts cited (dated):
• 2025-12-04: Upgraded to buy at $38.6; "see it recovering to $50 within ~4 months"
• Jan 1 2026: "Strong Buy" (EOY tax harvesting ending)

$BTC (Bitcoin) / $MSTR / $IBIT — Bitcoin longs

• Stance: "Always a great long." Dec 10 "Strong Buy" on all three.
• Evidence/catalysts cited (dated):
• 2026-01-04: Venezuela "shadow reserve" speculation — estimated 600,000 BTC seized → potential supply lock-up (speculative; sourced to Whale Hunting newsletter, Wilson Center, Reuters)
• MSTR: "Convertible notes won't trigger liquidation before 2029 halving"
• Jan 16: "In MSTR since $156; at ~1x MNAV after de-rating; good recovery"

---

C. Thematic threads

• AI Supply Chain Bottleneck Cascade (Dec 2025 → Jan 2026): The defining theme. He maps the photonics dependency chain: hyperscaler ASICs → OCS/optical transceivers → InP substrates → laser-grade InP feedstock. Tickers: NVDA, GOOGL, MSFT, AMZN, META → LITE, COHR, AAOI → AXTI, Sumitomo → Vital Materials, DOWA. Culminates in Jan 2026 China export ban on Japan cementing AXTI monopoly.

• Neocloud OpenAI Contagion / "Who Are the Real Tenants?" (Dec 11–Dec 17): ORCL/CRWV = OpenAI counterparty risk (can't pay obligations with $13B revenue vs $60B/year commitments). NBIS/IREN = MSFT/META backstop (AAA balance sheets). CIFR/WULF = GOOGL backstop. The Dec ORCL/AVGO earnings selloff was an indiscriminate "AI bubble" scare that incorrectly dragged isolated players. Tickers: ORCL, CRWV, APLD, CORZ (avoid/cautious) vs. NBIS, IREN, CIFR, WULF, HUT (buy the dip).

• SPEED Act + DC Permitting Reform (Dec 17): US government mandating permitting speed (1–2 year reviews, 150-day litigation shield). Fix for bear case #1 (DC delays/deferred revenue) and #2 (utilization lag destroying FCF). "Better than 3x rate cut." Tickers: NBIS, CRWV, IREN, CIFR, WULF, APLD.

• "Made in America" Photonics + Defense Materials (Jan 2026): Germanium export ban → LPTH Black Diamond monopoly. InP export controls → AXTI monopoly for Western supply. US pressing for vertical integration: AAOI as only US InP fab; Trump EO on HieFo InP assets. Tickers: LPTH, AXTI, AAOI, COHR, INTC.

• Venezuela Invasion / Nation Building (Jan 3–5 2026): US military takeover of Venezuela → nation-building portfolio: GDRZF, ASHM, CVX, TRGP, AVAV, HII, CF, GHM, GRZ.V, RMLFF. Separate Bitcoin angle (Venezuela "shadow reserve" 600K BTC speculation).

• Defense / DoD $1.5T Spend + Drone Warfare (Jan 2026): "Department of War stocks" — pure-play drone/edge AI companies with low P/S vs. peers: AIRO, AVAV, OSS, KRKNF, LPTH, ONDS, KTOS, SSYS (robotics frame).

• Robotics Supply Chain Mapping (Jan 15–16 2026): BOM mapping for Atlas, Optimus, Figure: ALGM, NOVT, VICR, OUST, AMBA, AEHR, RRX, TKR, MP, LSCC. His own picks: SSYS (skeleton), LPTH (vision/thermal). Identified Harmonic Drive disruption by China's Leaderdrive (40% cheaper) → TKR as US alternative.

• InP "Hunger Games" / Game Theory Materials Pricing: No precedent for a $700M company (AXTI) bottlenecking $15T+ in AI hyperscaler spend. Analog: Neon gas +2000% (2022), Dysprosium +2300% (2010), HBM +hundreds%. "TAM goes from $200M to $10B+ when hyperscalers fight for allocation." Tickers: AXTI, DOWA, Sumitomo, JX, Vital Materials.

---

D. Dated calls (track-record timeline)

• 2025-12-01 — $LITE — Initiated position at ~$316.5; thesis: Google TPU v7 OCS monopoly = 8–12% BOM share of every TPU pod
• 2025-12-01 — $AMKR — Added at ~$37.6; thesis: Made in America semi policy
• 2025-12-02 — $PL (Planet Labs) — Noted as "mega whale" since $3; up 300%+ on Google Suncatcher space DC project
• 2025-12-04 — $TTD — Upgraded to buy at $38.6; target $48–55 (~31.6% upside); "should recover to $50 within ~4 months when EOY tax harvesting stops"
• 2025-12-05 — $AAOI — Initiated small position; thesis: MSFT Maia + AMZN Trainium photonics play
• 2025-12-05 — $ORCL — Maintained "Avoid" before earnings; vindicated by 11% drop; "most of forward backlog dependent on OpenAI which doesn't have the funding"
• 2025-12-09 — $TSM — Added heavily at ~$302.5; thesis: AI backbone compounder
• 2025-12-09 — $CRCL — Added positions at ~$87.2; target rebound from float-unlock low
• 2025-12-10 — Rated full market (post-Fed 25bps cut): CRCL, COIN, AMKR, CRDO, IBIT, MSTR, AMZN, SMCI, TSM "Strong Buy"; KRUS, AVGO, NFLX, RKLB, TTD, NVDA "Buy"; RGTI, PLTR, WMT, ETH, TSLA, IONQ, ORCL, OKLO "Avoid"
• 2025-12-11 — $ORCL — Earnings miss; called sector contagion buying opportunity for isolated neoclouds (NBIS, CIFR, WULF, IREN) while avoiding ORCL and CRWV
• 2025-12-11 — $AAOI — Initiated formal position; "one of two photonics players I'm invested in"
• 2025-12-12 — $AVGO — Earnings -11.64%; called buying opportunity ("misunderstood backlog numbers")
• 2025-12-12 — $SNAP — Full thesis post at $7.64; "100%+ upside going into 2026 – early 2027"
• 2025-12-14 — $TTD — "Markets are starting to price in" the recovery (TTD +3.78% since Dec 4 entry)
• 2025-12-15 — $NBIS — "Never thought I'd see NBIS at $80 again… buying opportunity"; "NBIS easily blows past $250 once management projections achieved in 2026"
• 2025-12-17 — SPEED Act advance — Called "single biggest de-risking bill for neocloud sector this year; better than 3x rate cut"
• 2025-12-17 — $HUT — Reported $7B/15-year Anthropic/Fluidstack deal with $GOOGL backstop; up 25.28%
• 2025-12-19 — $NBIS — OpenAI raising at $750B → NBIS +10.28%; CRWV +15.85%; "fundamentals remain better than ever"
• 2025-12-20 — Official "5 high conviction multi-baggers for 2026" basket: NBIS, RKLB, ALAB, CRCL (new), LITE (new)
• 2025-12-21 — $CRCL — Full "1000%+ Circle Thesis" post; "go extraordinarily long at $84 ($18B MC)"
• 2025-12-22 — $LITE — Full thesis post: "up 316% YTD, might be 1000%+ by 2027"
• 2025-12-23 — $AAOI +24%, $LITE +5% same day as thesis posts; "AAOI is up 24% and LITE is 5% since my thesis today"
• 2025-12-23 — $MRVL — MSFT Maia 300 supply chain; "$10–$12B to MRVL in 2027 alone (doubles current revenue)"
• 2025-12-26 — $AXTI — First major post: "Warning: entire AI industry will likely be bottlenecked by AXTI ($700M) and SMTOY ($31.7B)"; ♥3,909 / 👁5.47M / ↻396 — highest-reach tweet this period
• 2025-12-27 — $AXTI — "Bottleneck within a bottleneck" post; 78% of laser-grade InP feedstock in China; ♥478 / 👁139K
• 2025-12-29 — $AXTI — CEO quote: "We are 40% of the InP supply chain"; ♥282 / 👁97K
• 2025-12-30 — $AXTI — InP "game theory" critical materials post; 7N Indium at $3,450+/kg; Northland $100M raise; ♥275 / 👁54K
• 2025-12-30 — Neoclouds in "Prove It" phase post; "asymmetry comes in if Nebius management scales to 20–30% EBIT margins"; ♥338 / 👁58K
• 2025-12-31 — $MRVL — Full thesis: "Benchmark disinformation caused -14% drop; MRVL has purchase orders in hand for all 2026; Maia 300 $7.72 EPS model = $231.60/share in 2 years"
• 2026-01-01 — "2026 Newsletter" — 10 thematic investment themes published; ♥754 / 👁282K
• 2026-01-02 — Jan 1 ratings published: NBIS, AXTI, TSM, CIFR, HUT, IREN, WULF "Strong Buy"; AAOI, COHR, MRVL, AVGO "Buy"
• 2026-01-02 — $AXTI — "InP Spread Arbitrage" deep-dive; AXT benefits from Chinese low-cost production → sells at Western premium; ♥189 / 👁64K
• 2026-01-03 — Venezuela invasion: First to post "How do you profit off US invasion of Venezuela?"; supply chain second-order effects (CF, CVX, AVAV, HII, etc.)
• 2026-01-04 — $GDRZF — "Nation Building port": GDRZF $1.68 entry ($200M MC, $8.1B claims); ♥1,163 / 👁236K
• 2026-01-05 — Venezuela nation-building port performance: GDRZF +95.83%, AVAV +14.7%, CVX +5.19%, ASHM +5.2%; ♥191 / 👁129K
• 2026-01-06 — $AXTI — China export ban on Japan (dual-use items); "AXT just became the monopoly of InP substrates"; +14% day; ♥479 / 👁393K
• 2026-01-06 — $CRDO — Added on 25.7% drop from CES misinformation (cable color + "cableless" Jensen comment misread)
• 2026-01-07 — $OSS — Initiated position at $155M MC; Venezuela usage validated; ♥1,005 / 👁804K
• 2026-01-08 — $AXTI — AH -29.54% on Q4 revenue miss; held; "people are overreacting to 2024 contracted backlog deferred by 1 quarter" ♥185 / 👁50K
• 2026-01-08 — 7N Indium ATH on SMM; AXTI effective monopoly for Western AI buildout
• 2026-01-09 — $VLN — Initiated position; discovered $82M ticker collision; full thesis: "1:1 MC/cash ratio for a $80M+ revenue, 69% margin fabless semi"; ♥270 / 👁129K; VLN +58% on Friday
• 2026-01-12 — $AXTI — InP supply shock timeline summary: China ban Jan 6 → Jiji confirms Jan 9 → SMM 7N ATH Jan 12 at $812–901/kg; ♥193 / 👁172K
• 2026-01-12 — Craig-Hallum re-rates $AXTI to Buy; $26 PT (+160%); "step-ladder validation"
• 2026-01-13 — $META — Entered at $625; accounting optics thesis (BBB one-time charge reversal Q4)
• 2026-01-13 — $SMCI — Added at $28.3; "Goldman Sachs analyst report extremely lazy"; margins will expand with DLC cycles
• 2026-01-14 — $LPTH — Initiated at ~$621M MC; ♥1,346 / 👁882K — top engagement tweet this period; stock +25% same day
• 2026-01-14 — Announced: "many picks up 60%+ this week — AXTI +60%, VLN +60%, AIRO +50%+ OSS +50%+"
• 2026-01-15 — $SSYS — Initiated as robotics humanoid skeleton play; "OpenAI robotics push is the inflection point"
• 2026-01-16 — Full robotics supply chain BOM: ALGM, NOVT, VICR, OUST, AMBA, RRX, TKR, MP, LSCC mapped to Atlas/Optimus/Figure; ♥751 / 👁153K
• 2026-01-17 — $INTC — High conviction long; "$234B vs TSM $1.5T — 7x return just for waiting"; ♥910 / 👁263K
• 2026-01-17 — Trump EO on HieFo InP assets — "US gov treating InP as national security emergency"; further validates AXTI thesis
• 2026-01-17 — Elon Musk sues OpenAI for $134B (prediction markets 59% Elon wins); potential contagion risk for ORCL, CRWV, AMD flagged
• 2026-01-18 — $LPTH — Full Germanium supply chain post: "US has zero domestic refining capacity until 2030; LPTH is sole source for Stinger missile seekers and Anduril Ghost drones"; ♥564 / 👁97K

---

Note: All prices and market-cap figures reflect Serenity's own citations from his tweets. Claims marked with "(speculative)" are his own labeled qualifications. The Venezuela Bitcoin "shadow reserve" (600K BTC) was explicitly acknowledged by Serenity as speculative inference from intelligence reporting, not confirmed chain-analysis data.

X Articles Supplement

This file stores compact, derived notes from Serenity's long-form X Articles. It intentionally does not store the full article text. Use it as a routing layer for article-backed theses, then cross-check current prices, filings, and company disclosures before acting.

Article Index

Durable Signals

SIVE / SIVEF - CPO Laser Chokepoint

The May 19 article is the strongest long-form source for Serenity's SIVE thesis. It frames Sivers Photonics as a high-beta merchant CW/DFB laser supplier sitting upstream of the CPO and 1.6T optical-transceiver ramp. The article separates evidence into public links, high-confidence customer mapping, and likely customer paths.

Publicly disclosed or directly mappable links:

• Jabil 1.6T pluggable optical-transceiver module.
• POET external light source collaboration.
• Ayar Labs supplier/partner path after other listed laser suppliers were

removed.

• O-Net / Enablence external light source path.
• Lightium AG thin-film lithium-niobate integration.
• Win Semi / GFS as scale-up and foundry de-risking paths.

High-confidence but still unconfirmed customer paths:

• Apple silicon-photonics / Apple Watch path.
• Aeva FMCW LiDAR path, with optionality into physical-AI and autonomous systems.
• Marvell / Celestial path where SIVE may supply lasers directly rather than

only through POET.

Likely or optionality paths:

• Lightmatter and Lightelligence private optical-compute ecosystems.
• AMD via GlobalFoundries CPO / MI500-related silicon-photonics work.
• Nokia / telecom route, inferred from Finland revenue and broader optical

ecosystem links.

• YSS / York Space / ALLSPACE and other defense-space paths tied to Golden Dome,

Space Force, SDA, and DoD work.

Portfolio interpretation: this article strengthens SIVE as the highest-context CPO laser bottleneck name in the corpus. It does not remove execution risk: hyperscalers can multi-source, many customer links remain NDA-based or inferential, and mass-production economics still need to show up in reported orders, revenue, and margin.

Hidden Gold Rush - Upstream Bottleneck Method

The January article formalizes his core method: do not stop at the obvious AI/defense/space winner; trace the bill of materials into tiny upstream markets where a small supplier can bottleneck a much larger TAM. AXTI/InP and LPTH/germanium are used as model cases. The useful workflow is:

1. Identify the downstream TAM that can expand by an order of magnitude. 2. Map the physical input that cannot scale quickly. 3. Find whether the supplier set is concentrated, geopolitically constrained, or ignored by institutions. 4. Prefer the smallest public company with the hardest-to-replicate chokepoint, then size for volatility and dilution risk.

Repeated framing worth carrying forward:

• He treats this as a "bottleneck cliff" rather than a generic AI-beta trade:

once a niche material becomes mandatory for AI, defense, or space, the market can stop valuing the supplier like a commodity producer and start valuing it like a constrained monopoly.

• He explicitly looks for a four-part setup: US onshoring/policy support, China

export controls, geopolitical disruption, and a new-technology ramp that consumes formerly niche materials.

• He cares about inventory-allocation game theory, not only end-demand growth:

if hyperscalers or defense primes race to pre-buy scarce inputs, price and bargaining power can rerate faster than unit volumes.

• His research list mixes raw materials, specialty processing, and obscure

enabling tools. The pattern is to search not just for miners, but also for processors, deposition, thermal, masking, vacuum, and radiation-hard supply points that sit upstream of future bottlenecks.

Portfolio interpretation: this article reinforces AXTI and the broader critical-materials watchlist, but it is a method article, not a fresh buy signal for every ticker mentioned.

Robotics Race - China Kill-Switch Over Hardware Supply Chains

The March article argues that humanoids and robotics are constrained by materials and manufacturing, not just AI software. Its main warning is that China controls major rare-earth mining, refining, and magnet capacity, so the US robotics stack has a strategic hardware vulnerability.

The article supports monitoring Western or ex-China exposure across:

• Rare earths and magnets: MP, UUUU, USAR, NEO.TSX, LYSDY.
• Structural and specialty materials: ATI, CRS, FCX, NB, MTRN, LGO, BMM, VNP,

TECK.

• Battery, graphite, and electrode materials: ALB, EAF, ALTM, SYR.

More specific durable takeaways from the article:

• He breaks the robotics bill of materials into three buckets that recur in his

later writing: magnet metals for frameless torque motors, structural metallurgy for reducers/roller screws, and compute-perception-power materials for semis, LiDAR, radios, and batteries.

• The thesis is not just "rare earths good." His actual claim is that the West

needs rebuild capacity across mining, separation, alloying/metallization, and finished magnet manufacturing; he treats midstream processing as the harder chokepoint than simply owning ore.

• He treats US robotics leaders as brain-heavy but body-dependent: software and

model leadership can still be bottlenecked if the physical actuator and magnet stack remains China-anchored.

• He frames gallium, germanium, graphite, copper, and lithium as part of the

same robotics sovereignty problem, not separate verticals. In practice, that means he reads robotics through a broader critical-materials basket rather than a single "humanoid pure-play" ticker.

Portfolio interpretation: this supports keeping small critical-material and rare-earth exposure on the watchlist, but the thesis is broad and geopolitical. It should not outrank higher-specificity CPO/laser evidence without current price, contract, and liquidity checks.

Clarity Act - Crypto Policy Risk

The February article is a crypto-market-structure critique. It is not relevant to the default AI/semi/CPO portfolio unless the user is evaluating BTC, stablecoin yield, crypto exchanges, crypto treasuries, or crypto legislation beta.

Its durable policy lens is:

• A stablecoin-yield ban is treated as a direct attack on crypto-native cash

parking and exchange liquidity, not a neutral consumer-protection rule.

• A 1:1 reserve regime is framed as structurally excluding algorithmic or

crypto-collateralized stablecoins, which in his view pushes liquidity and collateral demand back into the banking system.

• Bank-issued tokenized deposits are treated as a regulatory carve-out that lets

banks compete with stablecoins under softer rules.

• Custody, on-off-ramps, and settlement windows are the real chokepoints. He

reads any bank-only control there as bearish for crypto-native business models even if the headline says "market structure clarity."

Portfolio interpretation: when this lens is relevant, it is mainly a filter for liquidity, treasury, and custody risk in crypto equities or tokens. Treat it as Serenity's policy framing, not as a verified legal memo.

Maintenance Rule

Do not commit full X Article text to this public repo. Store only metadata, short summaries, durable thesis deltas, and portfolio-use rules. If private local full-text caching is needed for personal research, keep it outside the repo or under an ignored local path.

Skill Maintenance Playbook

Use this when updating the archive-derived skill from new @aleabitoreddit posts. The goal is to keep the skill current without turning it into a noisy transcript.

Maintenance Standard

1. Reuse before creating. Check existing SKILL.md, references/*.md, and analysis/*.md before adding new structure. Extend the closest existing section unless a repeated pattern clearly needs a new reference. 2. Require durable evidence. Promote a new post into the skill only when it adds at least one durable item:

• a repeated workflow or decision rule;
• a changed stance, new catalyst, or explicit invalidation;
• a supply-chain link, bottleneck, customer, foundry, contract, or timing

marker;

• a track-record update that changes calibration;
• terminology or framing likely to recur in future user questions.

3. Choose the smallest useful change.

• Update data/ for every new tweet.
• Update track-record.md for dated calls, validations, reversals, and

calibration events.

• Update theses.md for ticker-specific stance, evidence, risk, and latest

view changes.

• Update methodology.md only for reusable principles, checklists, and

anti-patterns.

• Update SKILL.md only for entry-point routing, workflows, or risk framing

that users need immediately. 4. Skip weak packaging. Do not add a skill note when a post is only a joke, short reaction, duplicate victory lap, one-off reply, or low-evidence opinion unless it materially changes a thesis or method. 5. Keep provenance compact. Mention the date and the concrete signal, not a long quote. Preserve full text in data/aleabitoreddit_tweets.json. For X Articles, do not commit the full article text. Store only metadata, short summaries, durable thesis deltas, and portfolio-use rules in references/articles.md. 6. Avoid broad rewrites. Make focused edits grounded in the latest posts. Split or reorganize only when repeated maintenance pain shows the current reference is too crowded or ambiguous.

Update Checklist

Before committing:

1. Fetch latest posts with xreach and dedupe by tweet id. 2. Refresh JSON, CSV, and ticker stats. 3. Fetch any newly visible X Article share tweets or article bodies with authenticated access. Keep full article text out of the repo; summarize only durable thesis deltas. 4. Classify each new post:

• data-only
• track-record
• ticker thesis
• methodology
• entry-point workflow
• article summary
• skip skill update

5. Make the smallest reference edit that captures the durable change. 6. Verify counts in README.md and SKILL.md. 7. Commit only when there is new data or a meaningful skill improvement.

Commit Guidance

• Use data: incremental tweet update (+<n>) <UTC ISO timestamp> for data-only

changes.

• Use skill/data: incremental tweet update (+<n>) <UTC ISO timestamp> when the

skill or references also change.

• Do not create empty commits.